id	sid	tid	token	lemma	pos
biht-305	1	1	1	1	X
biht-305	1	2	(	(	PUNCT
biht-305	1	3	page	page	NOUN
biht-305	1	4	number	number	NOUN
biht-305	1	5	not	not	PART
biht-305	1	6	for	for	ADP
biht-305	1	7	citation	citation	NOUN
biht-305	1	8	purpose	purpose	NOUN
biht-305	1	9	)	)	PUNCT
biht-305	1	10	blockchain	blockchain	PROPN
biht-305	1	11	in	in	ADP
biht-305	1	12	healthcare	healthcare	PROPN
biht-305	1	13	today	today	NOUN
biht-305	1	14	issn	issn	PROPN
biht-305	1	15	2573	2573	NUM
biht-305	1	16	-	-	SYM
biht-305	1	17	8240	8240	NUM
biht-305	1	18	opinion	opinion	NOUN
biht-305	1	19	/	/	SYM
biht-305	1	20	perspective	perspective	NOUN
biht-305	1	21	/	/	SYM
biht-305	1	22	commentary	commentary	NOUN
biht-305	1	23	leveraging	leverage	VERB
biht-305	1	24	decentralized	decentralize	VERB
biht-305	1	25	clinical	clinical	ADJ
biht-305	1	26	trial	trial	NOUN
biht-305	1	27	management	management	NOUN
biht-305	1	28	systems	system	NOUN
biht-305	1	29	(	(	PUNCT
biht-305	1	30	dctms	dctms	PROPN
biht-305	1	31	)	)	PUNCT
biht-305	1	32	to	to	PART
biht-305	1	33	advance	advance	VERB
biht-305	1	34	science	science	NOUN
biht-305	1	35	:	:	PUNCT
biht-305	1	36	exploring	explore	VERB
biht-305	1	37	challenges	challenge	NOUN
biht-305	1	38	related	relate	VERB
biht-305	1	39	to	to	ADP
biht-305	1	40	the	the	DET
biht-305	1	41	diffusion	diffusion	NOUN
biht-305	1	42	of	of	ADP
biht-305	1	43	innovation	innovation	NOUN
biht-305	1	44	and	and	CCONJ
biht-305	1	45	its	its	PRON
biht-305	1	46	execution	execution	NOUN
biht-305	1	47	rama	rama	PROPN
biht-305	1	48	krishna	krishna	PROPN
biht-305	1	49	rao	rao	PROPN
biht-305	1	50	,	,	PUNCT
biht-305	1	51	mba	mba	NOUN
biht-305	1	52	co	co	NOUN
biht-305	1	53	-	-	NOUN
biht-305	1	54	founder	founder	NOUN
biht-305	1	55	,	,	PUNCT
biht-305	1	56	ceo	ceo	NOUN
biht-305	1	57	,	,	PUNCT
biht-305	1	58	bloqcube	bloqcube	NOUN
biht-305	1	59	,	,	PUNCT
biht-305	1	60	piscataway	piscataway	PROPN
biht-305	1	61	,	,	PUNCT
biht-305	1	62	new	new	PROPN
biht-305	1	63	jersey	jersey	PROPN
biht-305	1	64	,	,	PUNCT
biht-305	1	65	usa	usa	PROPN
biht-305	1	66	corresponding	corresponding	PROPN
biht-305	1	67	author	author	NOUN
biht-305	1	68	:	:	PUNCT
biht-305	1	69	rama	rama	PROPN
biht-305	1	70	krishna	krishna	PROPN
biht-305	1	71	rao	rao	PROPN
biht-305	1	72	,	,	PUNCT
biht-305	1	73	email	email	NOUN
biht-305	1	74	:	:	PUNCT
biht-305	1	75	rama@bloqcube.com	rama@bloqcube.com	X
biht-305	2	1	doi	doi	NOUN
biht-305	2	2	:	:	PUNCT
biht-305	2	3	https://doi.org/10.30953/bhty.v7.305	https://doi.org/10.30953/bhty.v7.305	NOUN
biht-305	2	4	keywords	keyword	NOUN
biht-305	2	5	:	:	PUNCT
biht-305	2	6	blockchain	blockchain	NOUN
biht-305	2	7	,	,	PUNCT
biht-305	2	8	ctms	ctms	NOUN
biht-305	2	9	,	,	PUNCT
biht-305	2	10	decentralized	decentralize	VERB
biht-305	2	11	clinical	clinical	ADJ
biht-305	2	12	trials	trial	NOUN
biht-305	2	13	,	,	PUNCT
biht-305	2	14	drug	drug	NOUN
biht-305	2	15	development	development	NOUN
biht-305	2	16	,	,	PUNCT
biht-305	2	17	healthcare	healthcare	PROPN
biht-305	2	18	,	,	PUNCT
biht-305	2	19	pharmaceutical	pharmaceutical	NOUN
biht-305	2	20	industry	industry	NOUN
biht-305	2	21	,	,	PUNCT
biht-305	2	22	solutions	solution	NOUN
biht-305	2	23	,	,	PUNCT
biht-305	2	24	decentralized	decentralize	VERB
biht-305	2	25	clinical	clinical	ADJ
biht-305	2	26	trials	trial	NOUN
biht-305	2	27	management	management	NOUN
biht-305	2	28	systems	system	NOUN
biht-305	2	29	,	,	PUNCT
biht-305	2	30	dctms	dctms	PROPN
biht-305	2	31	abstract	abstract	ADJ
biht-305	2	32	decentralized	decentralize	VERB
biht-305	2	33	clinical	clinical	ADJ
biht-305	2	34	trials	trial	NOUN
biht-305	2	35	(	(	PUNCT
biht-305	2	36	dcts	dct	NOUN
biht-305	2	37	)	)	PUNCT
biht-305	2	38	recently	recently	ADV
biht-305	2	39	gained	gain	VERB
biht-305	2	40	attention	attention	NOUN
biht-305	2	41	in	in	ADP
biht-305	2	42	research	research	NOUN
biht-305	2	43	necessary	necessary	ADJ
biht-305	2	44	for	for	ADP
biht-305	2	45	drug	drug	NOUN
biht-305	2	46	development	development	NOUN
biht-305	2	47	.	.	PUNCT
biht-305	3	1	while	while	SCONJ
biht-305	3	2	the	the	DET
biht-305	3	3	covid-19	covid-19	PROPN
biht-305	3	4	pandemic	pandemic	NOUN
biht-305	3	5	proved	prove	VERB
biht-305	3	6	to	to	PART
biht-305	3	7	be	be	AUX
biht-305	3	8	a	a	DET
biht-305	3	9	challenging	challenging	ADJ
biht-305	3	10	time	time	NOUN
biht-305	3	11	in	in	ADP
biht-305	3	12	this	this	DET
biht-305	3	13	arena	arena	NOUN
biht-305	3	14	,	,	PUNCT
biht-305	3	15	drug	drug	NOUN
biht-305	3	16	development	development	NOUN
biht-305	3	17	was	be	AUX
biht-305	3	18	a	a	DET
biht-305	3	19	critical	critical	ADJ
biht-305	3	20	area	area	NOUN
biht-305	3	21	of	of	ADP
biht-305	3	22	emphasis	emphasis	NOUN
biht-305	3	23	in	in	ADP
biht-305	3	24	the	the	DET
biht-305	3	25	rapid	rapid	ADJ
biht-305	3	26	advancement	advancement	NOUN
biht-305	3	27	of	of	ADP
biht-305	3	28	vaccines	vaccine	NOUN
biht-305	3	29	.	.	PUNCT
biht-305	4	1	the	the	DET
biht-305	4	2	dcts	dct	NOUN
biht-305	4	3	were	be	AUX
biht-305	4	4	necessary	necessary	ADJ
biht-305	4	5	to	to	PART
biht-305	4	6	allow	allow	VERB
biht-305	4	7	research	research	NOUN
biht-305	4	8	activities	activity	NOUN
biht-305	4	9	to	to	PART
biht-305	4	10	occur	occur	VERB
biht-305	4	11	across	across	ADP
biht-305	4	12	many	many	ADJ
biht-305	4	13	locations	location	NOUN
biht-305	4	14	.	.	PUNCT
biht-305	5	1	the	the	DET
biht-305	5	2	use	use	NOUN
biht-305	5	3	of	of	ADP
biht-305	5	4	dcts	dct	NOUN
biht-305	5	5	can	can	AUX
biht-305	5	6	profoundly	profoundly	ADV
biht-305	5	7	impact	impact	VERB
biht-305	5	8	reshaping	reshape	VERB
biht-305	5	9	healthcare	healthcare	NOUN
biht-305	5	10	by	by	ADP
biht-305	5	11	enabling	enable	VERB
biht-305	5	12	participants	participant	NOUN
biht-305	5	13	to	to	PART
biht-305	5	14	partake	partake	VERB
biht-305	5	15	in	in	ADP
biht-305	5	16	clinical	clinical	ADJ
biht-305	5	17	trials	trial	NOUN
biht-305	5	18	remotely	remotely	ADV
biht-305	5	19	;	;	PUNCT
biht-305	5	20	however	however	ADV
biht-305	5	21	,	,	PUNCT
biht-305	5	22	implementation	implementation	NOUN
biht-305	5	23	challenges	challenge	NOUN
biht-305	5	24	must	must	AUX
biht-305	5	25	be	be	AUX
biht-305	5	26	considered	consider	VERB
biht-305	5	27	as	as	SCONJ
biht-305	5	28	technology	technology	NOUN
biht-305	5	29	expands	expand	VERB
biht-305	5	30	.	.	PUNCT
biht-305	6	1	a	a	DET
biht-305	6	2	working	work	VERB
biht-305	6	3	group	group	NOUN
biht-305	6	4	of	of	ADP
biht-305	6	5	participants	participant	NOUN
biht-305	6	6	was	be	AUX
biht-305	6	7	assembled	assemble	VERB
biht-305	6	8	during	during	ADP
biht-305	6	9	an	an	DET
biht-305	6	10	interactive	interactive	ADJ
biht-305	6	11	learning	learning	NOUN
biht-305	6	12	exercise	exercise	NOUN
biht-305	6	13	at	at	ADP
biht-305	6	14	the	the	DET
biht-305	6	15	conv2x	conv2x	NOUN
biht-305	6	16	conference	conference	NOUN
biht-305	6	17	(	(	PUNCT
biht-305	6	18	2023	2023	NUM
biht-305	6	19	)	)	PUNCT
biht-305	6	20	to	to	PART
biht-305	6	21	explore	explore	VERB
biht-305	6	22	challenges	challenge	NOUN
biht-305	6	23	related	relate	VERB
biht-305	6	24	to	to	ADP
biht-305	6	25	the	the	DET
biht-305	6	26	diffusion	diffusion	NOUN
biht-305	6	27	of	of	ADP
biht-305	6	28	innovation	innovation	NOUN
biht-305	6	29	among	among	ADP
biht-305	6	30	key	key	ADJ
biht-305	6	31	stakeholders	stakeholder	NOUN
biht-305	6	32	.	.	PUNCT
biht-305	7	1	pain	pain	NOUN
biht-305	7	2	points	point	NOUN
biht-305	7	3	experienced	experience	VERB
biht-305	7	4	with	with	ADP
biht-305	7	5	using	use	VERB
biht-305	7	6	and	and	CCONJ
biht-305	7	7	implementing	implement	VERB
biht-305	7	8	technologies	technology	NOUN
biht-305	7	9	were	be	AUX
biht-305	7	10	identified	identify	VERB
biht-305	7	11	,	,	PUNCT
biht-305	7	12	and	and	CCONJ
biht-305	7	13	an	an	DET
biht-305	7	14	innovative	innovative	ADJ
biht-305	7	15	solution	solution	NOUN
biht-305	7	16	using	use	VERB
biht-305	7	17	a	a	DET
biht-305	7	18	blockchain	blockchain	NOUN
biht-305	7	19	-	-	PUNCT
biht-305	7	20	anchored	anchor	VERB
biht-305	7	21	option	option	NOUN
biht-305	7	22	was	be	AUX
biht-305	7	23	presented	present	VERB
biht-305	7	24	.	.	PUNCT
biht-305	8	1	participants	participant	NOUN
biht-305	8	2	were	be	AUX
biht-305	8	3	divided	divide	VERB
biht-305	8	4	into	into	ADP
biht-305	8	5	three	three	NUM
biht-305	8	6	stakeholder	stakeholder	NOUN
biht-305	8	7	groups	group	NOUN
biht-305	8	8	:	:	PUNCT
biht-305	8	9	patients	patient	NOUN
biht-305	8	10	,	,	PUNCT
biht-305	8	11	payers	payer	NOUN
biht-305	8	12	,	,	PUNCT
biht-305	8	13	and	and	CCONJ
biht-305	8	14	pharmaceutical	pharmaceutical	NOUN
biht-305	8	15	sponsors	sponsor	NOUN
biht-305	8	16	.	.	PUNCT
biht-305	9	1	after	after	ADP
biht-305	9	2	a	a	DET
biht-305	9	3	time	time	NOUN
biht-305	9	4	of	of	ADP
biht-305	9	5	discussion	discussion	NOUN
biht-305	9	6	,	,	PUNCT
biht-305	9	7	the	the	DET
biht-305	9	8	groups	group	NOUN
biht-305	9	9	reconvened	reconvene	VERB
biht-305	9	10	for	for	ADP
biht-305	9	11	review	review	NOUN
biht-305	9	12	.	.	PUNCT
biht-305	10	1	several	several	ADJ
biht-305	10	2	themes	theme	NOUN
biht-305	10	3	that	that	PRON
biht-305	10	4	can	can	AUX
biht-305	10	5	be	be	AUX
biht-305	10	6	supported	support	VERB
biht-305	10	7	by	by	ADP
biht-305	10	8	blockchain	blockchain	PROPN
biht-305	10	9	technology	technology	PROPN
biht-305	10	10	emerged	emerge	VERB
biht-305	10	11	.	.	PUNCT
biht-305	11	1	these	these	PRON
biht-305	11	2	include	include	VERB
biht-305	11	3	enhanced	enhanced	ADJ
biht-305	11	4	efficiencies	efficiency	NOUN
biht-305	11	5	,	,	PUNCT
biht-305	11	6	patient	patient	ADJ
biht-305	11	7	experience	experience	NOUN
biht-305	11	8	,	,	PUNCT
biht-305	11	9	and	and	CCONJ
biht-305	11	10	demographic	demographic	ADJ
biht-305	11	11	diversity	diversity	NOUN
biht-305	11	12	,	,	PUNCT
biht-305	11	13	as	as	ADV
biht-305	11	14	well	well	ADV
biht-305	11	15	as	as	ADP
biht-305	11	16	data	data	NOUN
biht-305	11	17	integrity	integrity	NOUN
biht-305	11	18	,	,	PUNCT
biht-305	11	19	privacy	privacy	NOUN
biht-305	11	20	,	,	PUNCT
biht-305	11	21	security	security	NOUN
biht-305	11	22	,	,	PUNCT
biht-305	11	23	and	and	CCONJ
biht-305	11	24	cost	cost	NOUN
biht-305	11	25	-	-	PUNCT
biht-305	11	26	effectiveness	effectiveness	NOUN
biht-305	11	27	.	.	PUNCT
biht-305	12	1	future	future	ADJ
biht-305	12	2	research	research	NOUN
biht-305	12	3	might	might	AUX
biht-305	12	4	focus	focus	VERB
biht-305	12	5	on	on	ADP
biht-305	12	6	strategies	strategy	NOUN
biht-305	12	7	to	to	PART
biht-305	12	8	facilitate	facilitate	VERB
biht-305	12	9	the	the	DET
biht-305	12	10	adoption	adoption	NOUN
biht-305	12	11	of	of	ADP
biht-305	12	12	the	the	DET
biht-305	12	13	idea	idea	NOUN
biht-305	12	14	across	across	ADP
biht-305	12	15	key	key	ADJ
biht-305	12	16	stakeholder	stakeholder	NOUN
biht-305	12	17	groups	group	NOUN
biht-305	12	18	.	.	PUNCT
biht-305	13	1	received	receive	VERB
biht-305	13	2	:	:	PUNCT
biht-305	13	3	march	march	PROPN
biht-305	13	4	10	10	NUM
biht-305	13	5	,	,	PUNCT
biht-305	13	6	2024	2024	NUM
biht-305	13	7	;	;	PUNCT
biht-305	13	8	accepted	accept	VERB
biht-305	13	9	:	:	PUNCT
biht-305	13	10	april	april	PROPN
biht-305	13	11	4	4	NUM
biht-305	13	12	,	,	PUNCT
biht-305	13	13	2024	2024	NUM
biht-305	13	14	;	;	PUNCT
biht-305	13	15	published	publish	VERB
biht-305	13	16	:	:	PUNCT
biht-305	13	17	april	april	PROPN
biht-305	13	18	30	30	NUM
biht-305	13	19	,	,	PUNCT
biht-305	13	20	2024	2024	NUM
biht-305	13	21	clinical	clinical	ADJ
biht-305	13	22	trials	trial	NOUN
biht-305	13	23	and	and	CCONJ
biht-305	13	24	their	their	PRON
biht-305	13	25	associated	associated	ADJ
biht-305	13	26	regulatory	regulatory	ADJ
biht-305	13	27	processes	process	NOUN
biht-305	13	28	are	be	AUX
biht-305	13	29	critical	critical	ADJ
biht-305	13	30	to	to	ADP
biht-305	13	31	drug	drug	NOUN
biht-305	13	32	development	development	NOUN
biht-305	13	33	.	.	PUNCT
biht-305	14	1	the	the	DET
biht-305	14	2	covid-19	covid-19	PROPN
biht-305	14	3	pandemic	pandemic	NOUN
biht-305	14	4	proved	prove	VERB
biht-305	14	5	to	to	PART
biht-305	14	6	be	be	AUX
biht-305	14	7	a	a	DET
biht-305	14	8	challenging	challenging	ADJ
biht-305	14	9	time	time	NOUN
biht-305	14	10	,	,	PUNCT
biht-305	14	11	yet	yet	CCONJ
biht-305	14	12	it	it	PRON
biht-305	14	13	spawned	spawn	VERB
biht-305	14	14	a	a	DET
biht-305	14	15	host	host	NOUN
biht-305	14	16	of	of	ADP
biht-305	14	17	innovations	innovation	NOUN
biht-305	14	18	.	.	PUNCT
biht-305	15	1	drug	drug	NOUN
biht-305	15	2	development	development	NOUN
biht-305	15	3	was	be	AUX
biht-305	15	4	a	a	DET
biht-305	15	5	critical	critical	ADJ
biht-305	15	6	area	area	NOUN
biht-305	15	7	of	of	ADP
biht-305	15	8	emphasis	emphasis	NOUN
biht-305	15	9	for	for	ADP
biht-305	15	10	developing	develop	VERB
biht-305	15	11	covid-19	covid-19	PROPN
biht-305	15	12	vaccines	vaccine	NOUN
biht-305	15	13	,	,	PUNCT
biht-305	15	14	and	and	CCONJ
biht-305	15	15	decentralized	decentralize	VERB
biht-305	15	16	clinical	clinical	ADJ
biht-305	15	17	trials	trial	NOUN
biht-305	15	18	(	(	PUNCT
biht-305	15	19	dcts	dct	NOUN
biht-305	15	20	)	)	PUNCT
biht-305	15	21	were	be	AUX
biht-305	15	22	necessary	necessary	ADJ
biht-305	15	23	to	to	PART
biht-305	15	24	allow	allow	VERB
biht-305	15	25	research	research	NOUN
biht-305	15	26	activities	activity	NOUN
biht-305	15	27	to	to	PART
biht-305	15	28	continue.1–3	continue.1–3	VERB
biht-305	15	29	in	in	ADP
biht-305	15	30	a	a	DET
biht-305	15	31	dct	dct	PROPN
biht-305	15	32	,	,	PUNCT
biht-305	15	33	some	some	PRON
biht-305	15	34	or	or	CCONJ
biht-305	15	35	all	all	DET
biht-305	15	36	trial	trial	NOUN
biht-305	15	37	activities	activity	NOUN
biht-305	15	38	occur	occur	VERB
biht-305	15	39	at	at	ADP
biht-305	15	40	locations	location	NOUN
biht-305	15	41	other	other	ADJ
biht-305	15	42	than	than	ADP
biht-305	15	43	a	a	DET
biht-305	15	44	traditional	traditional	ADJ
biht-305	15	45	clinical	clinical	ADJ
biht-305	15	46	site	site	NOUN
biht-305	15	47	,	,	PUNCT
biht-305	15	48	including	include	VERB
biht-305	15	49	the	the	DET
biht-305	15	50	patient	patient	NOUN
biht-305	15	51	’s	’s	PART
biht-305	15	52	home	home	NOUN
biht-305	15	53	or	or	CCONJ
biht-305	15	54	a	a	DET
biht-305	15	55	local	local	ADJ
biht-305	15	56	healthcare	healthcare	NOUN
biht-305	15	57	facility	facility	NOUN
biht-305	15	58	or	or	CCONJ
biht-305	15	59	laboratory.1	laboratory.1	PROPN
biht-305	15	60	in	in	ADP
biht-305	15	61	recent	recent	ADJ
biht-305	15	62	years	year	NOUN
biht-305	15	63	,	,	PUNCT
biht-305	15	64	significant	significant	ADJ
biht-305	15	65	strides	stride	NOUN
biht-305	15	66	in	in	ADP
biht-305	15	67	technology	technology	NOUN
biht-305	15	68	have	have	AUX
biht-305	15	69	occurred	occur	VERB
biht-305	15	70	,	,	PUNCT
biht-305	15	71	which	which	PRON
biht-305	15	72	make	make	VERB
biht-305	15	73	it	it	PRON
biht-305	15	74	widely	widely	ADV
biht-305	15	75	available	available	ADJ
biht-305	15	76	(	(	PUNCT
biht-305	15	77	e.g.	e.g.	ADV
biht-305	15	78	,	,	PUNCT
biht-305	15	79	smartphones	smartphone	NOUN
biht-305	15	80	,	,	PUNCT
biht-305	15	81	artificial	artificial	ADJ
biht-305	15	82	intelligence	intelligence	NOUN
biht-305	15	83	(	(	PUNCT
biht-305	15	84	ai	ai	NOUN
biht-305	15	85	)	)	PUNCT
biht-305	15	86	,	,	PUNCT
biht-305	15	87	wearables	wearable	NOUN
biht-305	15	88	,	,	PUNCT
biht-305	15	89	etc	etc	X
biht-305	15	90	.	.	X
biht-305	15	91	)	)	PUNCT
biht-305	15	92	.	.	PUNCT
biht-305	16	1	regardless	regardless	ADV
biht-305	16	2	of	of	ADP
biht-305	16	3	the	the	DET
biht-305	16	4	stunning	stunning	ADJ
biht-305	16	5	advancements	advancement	NOUN
biht-305	16	6	and	and	CCONJ
biht-305	16	7	the	the	DET
biht-305	16	8	critical	critical	ADJ
biht-305	16	9	nature	nature	NOUN
biht-305	16	10	of	of	ADP
biht-305	16	11	data	datum	NOUN
biht-305	16	12	sharing	share	VERB
biht-305	16	13	necessary	necessary	ADJ
biht-305	16	14	for	for	ADP
biht-305	16	15	the	the	DET
biht-305	16	16	timely	timely	ADJ
biht-305	16	17	approval	approval	NOUN
biht-305	16	18	of	of	ADP
biht-305	16	19	new	new	ADJ
biht-305	16	20	drugs	drug	NOUN
biht-305	16	21	,	,	PUNCT
biht-305	16	22	the	the	DET
biht-305	16	23	use	use	NOUN
biht-305	16	24	of	of	ADP
biht-305	16	25	select	select	ADJ
biht-305	16	26	emerging	emerge	VERB
biht-305	16	27	technologies	technology	NOUN
biht-305	16	28	in	in	ADP
biht-305	16	29	clinical	clinical	ADJ
biht-305	16	30	trials	trial	NOUN
biht-305	16	31	lags	lag	VERB
biht-305	16	32	.	.	PUNCT
biht-305	17	1	the	the	DET
biht-305	17	2	essence	essence	NOUN
biht-305	17	3	of	of	ADP
biht-305	17	4	“	"	PUNCT
biht-305	17	5	decentralization	decentralization	NOUN
biht-305	17	6	”	"	PUNCT
biht-305	17	7	represents	represent	VERB
biht-305	17	8	a	a	DET
biht-305	17	9	shift	shift	NOUN
biht-305	17	10	in	in	ADP
biht-305	17	11	the	the	DET
biht-305	17	12	locus	locus	NOUN
biht-305	17	13	of	of	ADP
biht-305	17	14	power	power	NOUN
biht-305	17	15	or	or	CCONJ
biht-305	17	16	authority	authority	NOUN
biht-305	17	17	.	.	PUNCT
biht-305	18	1	in	in	ADP
biht-305	18	2	a	a	DET
biht-305	18	3	fully	fully	ADV
biht-305	18	4	decentralized	decentralize	VERB
biht-305	18	5	model	model	NOUN
biht-305	18	6	,	,	PUNCT
biht-305	18	7	study	study	NOUN
biht-305	18	8	activities	activity	NOUN
biht-305	18	9	are	be	AUX
biht-305	18	10	executed	execute	VERB
biht-305	18	11	without	without	ADP
biht-305	18	12	in	in	ADP
biht-305	18	13	-	-	PUNCT
biht-305	18	14	person	person	NOUN
biht-305	18	15	contact	contact	NOUN
biht-305	18	16	.	.	PUNCT
biht-305	19	1	this	this	DET
biht-305	19	2	description	description	NOUN
biht-305	19	3	suggests	suggest	VERB
biht-305	19	4	that	that	SCONJ
biht-305	19	5	dcts	dct	NOUN
biht-305	19	6	would	would	AUX
biht-305	19	7	have	have	VERB
biht-305	19	8	a	a	DET
biht-305	19	9	structural	structural	ADJ
biht-305	19	10	reordering	reordering	NOUN
biht-305	19	11	,	,	PUNCT
biht-305	19	12	yet	yet	CCONJ
biht-305	19	13	that	that	PRON
biht-305	19	14	has	have	AUX
biht-305	19	15	not	not	PART
biht-305	19	16	been	be	AUX
biht-305	19	17	the	the	DET
biht-305	19	18	case	case	NOUN
biht-305	19	19	.	.	PUNCT
biht-305	20	1	the	the	DET
biht-305	20	2	dcts	dct	NOUN
biht-305	20	3	in	in	ADP
biht-305	20	4	the	the	DET
biht-305	20	5	current	current	ADJ
biht-305	20	6	state	state	NOUN
biht-305	20	7	are	be	AUX
biht-305	20	8	a	a	DET
biht-305	20	9	misnomer	misnomer	NOUN
biht-305	20	10	in	in	ADP
biht-305	20	11	that	that	SCONJ
biht-305	20	12	they	they	PRON
biht-305	20	13	represent	represent	VERB
biht-305	20	14	a	a	DET
biht-305	20	15	change	change	NOUN
biht-305	20	16	in	in	ADP
biht-305	20	17	the	the	DET
biht-305	20	18	locus	locus	NOUN
biht-305	20	19	of	of	ADP
biht-305	20	20	trial	trial	NOUN
biht-305	20	21	conduct	conduct	NOUN
biht-305	20	22	/	/	SYM
biht-305	20	23	locations	location	NOUN
biht-305	20	24	—	—	PUNCT
biht-305	20	25	from	from	ADP
biht-305	20	26	sites	site	NOUN
biht-305	20	27	to	to	ADP
biht-305	20	28	alternative	alternative	ADJ
biht-305	20	29	locations	location	NOUN
biht-305	20	30	(	(	PUNCT
biht-305	20	31	e.g.	e.g.	ADV
biht-305	20	32	,	,	PUNCT
biht-305	20	33	patient	patient	ADJ
biht-305	20	34	homes	home	NOUN
biht-305	20	35	)	)	PUNCT
biht-305	20	36	.	.	PUNCT
biht-305	21	1	currently	currently	ADV
biht-305	21	2	,	,	PUNCT
biht-305	21	3	dcts	dct	NOUN
biht-305	21	4	exist	exist	VERB
biht-305	21	5	along	along	ADP
biht-305	21	6	a	a	DET
biht-305	21	7	continuum	continuum	NOUN
biht-305	21	8	,	,	PUNCT
biht-305	21	9	with	with	ADP
biht-305	21	10	some	some	PRON
biht-305	21	11	believing	believe	VERB
biht-305	21	12	that	that	SCONJ
biht-305	21	13	many	many	ADJ
biht-305	21	14	trials	trial	NOUN
biht-305	21	15	(	(	PUNCT
biht-305	21	16	e.g.	e.g.	ADV
biht-305	21	17	,	,	PUNCT
biht-305	21	18	oncology	oncology	NOUN
biht-305	21	19	-	-	PUNCT
biht-305	21	20	related	relate	VERB
biht-305	21	21	)	)	PUNCT
biht-305	21	22	may	may	AUX
biht-305	21	23	never	never	ADV
biht-305	21	24	be	be	AUX
biht-305	21	25	fully	fully	ADV
biht-305	21	26	decentralized	decentralize	VERB
biht-305	21	27	due	due	ADP
biht-305	21	28	to	to	ADP
biht-305	21	29	complexity	complexity	NOUN
biht-305	21	30	and	and	CCONJ
biht-305	21	31	sponsor	sponsor	NOUN
biht-305	21	32	-	-	PUNCT
biht-305	21	33	mandated	mandate	VERB
biht-305	21	34	in	in	ADP
biht-305	21	35	-	-	PUNCT
biht-305	21	36	person	person	NOUN
biht-305	21	37	interactions	interaction	NOUN
biht-305	21	38	for	for	ADP
biht-305	21	39	safety	safety	NOUN
biht-305	21	40	and	and	CCONJ
biht-305	21	41	regulatory	regulatory	ADJ
biht-305	22	1	purposes.1,4	purposes.1,4	PROPN
biht-305	22	2	mailto:rama@bloqcube.com	mailto:rama@bloqcube.com	PROPN
biht-305	22	3	https://doi.org/10.30953/bhty.v7.305	https://doi.org/10.30953/bhty.v7.305	NOUN
biht-305	22	4	citation	citation	NOUN
biht-305	22	5	:	:	PUNCT
biht-305	23	1	blockchain	blockchain	NOUN
biht-305	23	2	in	in	ADP
biht-305	23	3	healthcare	healthcare	NOUN
biht-305	23	4	today	today	NOUN
biht-305	23	5	2024	2024	NUM
biht-305	23	6	,	,	PUNCT
biht-305	23	7	7	7	NUM
biht-305	23	8	:	:	SYM
biht-305	23	9	305	305	NUM
biht-305	23	10	https://doi.org/10.30953/bhty.v7.305	https://doi.org/10.30953/bhty.v7.305	NOUN
biht-305	23	11	2	2	NUM
biht-305	23	12	(	(	PUNCT
biht-305	23	13	page	page	NOUN
biht-305	23	14	number	number	NOUN
biht-305	23	15	not	not	PART
biht-305	23	16	for	for	ADP
biht-305	23	17	citation	citation	NOUN
biht-305	23	18	purpose	purpose	NOUN
biht-305	23	19	)	)	PUNCT
biht-305	23	20	rama	rama	PROPN
biht-305	23	21	krishna	krishna	PROPN
biht-305	23	22	rao	rao	PROPN
biht-305	23	23	aware	aware	ADJ
biht-305	23	24	of	of	ADP
biht-305	23	25	dcts	dct	NOUN
biht-305	23	26	’	'	PUNCT
biht-305	23	27	promise	promise	NOUN
biht-305	23	28	and	and	CCONJ
biht-305	23	29	challenges	challenge	NOUN
biht-305	23	30	,	,	PUNCT
biht-305	23	31	the	the	DET
biht-305	23	32	u.s	u.s	PROPN
biht-305	23	33	.	.	PROPN
biht-305	23	34	food	food	PROPN
biht-305	23	35	and	and	CCONJ
biht-305	23	36	drug	drug	PROPN
biht-305	23	37	administration	administration	PROPN
biht-305	23	38	(	(	PUNCT
biht-305	23	39	fda	fda	PROPN
biht-305	23	40	)	)	PUNCT
biht-305	23	41	is	be	AUX
biht-305	23	42	issuing	issue	VERB
biht-305	23	43	resources	resource	NOUN
biht-305	23	44	and	and	CCONJ
biht-305	23	45	guidelines	guideline	NOUN
biht-305	23	46	to	to	PART
biht-305	23	47	address	address	VERB
biht-305	23	48	their	their	PRON
biht-305	23	49	novel	novel	ADJ
biht-305	23	50	development	development	NOUN
biht-305	23	51	in	in	ADP
biht-305	23	52	healthcare.1	healthcare.1	PROPN
biht-305	23	53	simultaneously	simultaneously	ADV
biht-305	23	54	,	,	PUNCT
biht-305	23	55	technical	technical	ADJ
biht-305	23	56	hurdles	hurdle	NOUN
biht-305	23	57	that	that	PRON
biht-305	23	58	slow	slow	VERB
biht-305	23	59	their	their	PRON
biht-305	23	60	adoption	adoption	NOUN
biht-305	23	61	should	should	AUX
biht-305	23	62	also	also	ADV
biht-305	23	63	be	be	AUX
biht-305	23	64	explored	explore	VERB
biht-305	23	65	.	.	PUNCT
biht-305	24	1	this	this	DET
biht-305	24	2	exploratory	exploratory	ADJ
biht-305	24	3	exercise	exercise	NOUN
biht-305	24	4	aimed	aim	VERB
biht-305	24	5	to	to	PART
biht-305	24	6	assess	assess	VERB
biht-305	24	7	,	,	PUNCT
biht-305	24	8	analyze	analyze	VERB
biht-305	24	9	,	,	PUNCT
biht-305	24	10	and	and	CCONJ
biht-305	24	11	synthesize	synthesize	VERB
biht-305	24	12	stakeholder	stakeholder	NOUN
biht-305	24	13	opinions	opinion	NOUN
biht-305	24	14	related	relate	VERB
biht-305	24	15	to	to	ADP
biht-305	24	16	the	the	DET
biht-305	24	17	current	current	ADJ
biht-305	24	18	challenges	challenge	NOUN
biht-305	24	19	slowing	slow	VERB
biht-305	24	20	the	the	DET
biht-305	24	21	diffusion	diffusion	NOUN
biht-305	24	22	of	of	ADP
biht-305	24	23	innovation	innovation	NOUN
biht-305	24	24	for	for	ADP
biht-305	24	25	dcts	dct	NOUN
biht-305	24	26	and	and	CCONJ
biht-305	24	27	capture	capture	VERB
biht-305	24	28	considerations	consideration	NOUN
biht-305	24	29	among	among	ADP
biht-305	24	30	three	three	NUM
biht-305	24	31	key	key	ADJ
biht-305	24	32	groups	group	NOUN
biht-305	24	33	(	(	PUNCT
biht-305	24	34	i.e.	i.e.	X
biht-305	24	35	,	,	PUNCT
biht-305	24	36	patients	patient	NOUN
biht-305	24	37	,	,	PUNCT
biht-305	24	38	payers	payer	NOUN
biht-305	24	39	,	,	PUNCT
biht-305	24	40	and	and	CCONJ
biht-305	24	41	pharmaceutical	pharmaceutical	NOUN
biht-305	24	42	sponsors	sponsor	NOUN
biht-305	24	43	)	)	PUNCT
biht-305	24	44	.	.	PUNCT
biht-305	25	1	the	the	DET
biht-305	25	2	diffusion	diffusion	NOUN
biht-305	25	3	of	of	ADP
biht-305	25	4	innovation	innovation	NOUN
biht-305	25	5	refers	refer	VERB
biht-305	25	6	to	to	ADP
biht-305	25	7	a	a	DET
biht-305	25	8	five	five	NUM
biht-305	25	9	-	-	PUNCT
biht-305	25	10	step	step	NOUN
biht-305	25	11	process	process	NOUN
biht-305	25	12	(	(	PUNCT
biht-305	25	13	i.e.	i.e.	X
biht-305	25	14	,	,	PUNCT
biht-305	25	15	knowledge	knowledge	NOUN
biht-305	25	16	,	,	PUNCT
biht-305	25	17	persuasion	persuasion	NOUN
biht-305	25	18	,	,	PUNCT
biht-305	25	19	decision	decision	NOUN
biht-305	25	20	,	,	PUNCT
biht-305	25	21	implementation	implementation	NOUN
biht-305	25	22	,	,	PUNCT
biht-305	25	23	and	and	CCONJ
biht-305	25	24	confirmation	confirmation	NOUN
biht-305	25	25	)	)	PUNCT
biht-305	25	26	by	by	ADP
biht-305	25	27	which	which	PRON
biht-305	25	28	an	an	DET
biht-305	25	29	individual	individual	NOUN
biht-305	25	30	decides	decide	VERB
biht-305	25	31	to	to	PART
biht-305	25	32	adopt	adopt	VERB
biht-305	25	33	an	an	DET
biht-305	25	34	idea	idea	NOUN
biht-305	25	35	at	at	ADP
biht-305	25	36	a	a	DET
biht-305	25	37	certain	certain	ADJ
biht-305	25	38	speed.5	speed.5	PROPN
biht-305	25	39	methods	method	NOUN
biht-305	25	40	conference	conference	NOUN
biht-305	25	41	session	session	NOUN
biht-305	25	42	/	/	SYM
biht-305	25	43	workgroup	workgroup	NOUN
biht-305	25	44	conv2x	conv2x	NOUN
biht-305	25	45	is	be	AUX
biht-305	25	46	a	a	DET
biht-305	25	47	global	global	ADJ
biht-305	25	48	conference	conference	NOUN
biht-305	25	49	advancing	advance	VERB
biht-305	25	50	the	the	DET
biht-305	25	51	business	business	NOUN
biht-305	25	52	of	of	ADP
biht-305	25	53	health	health	NOUN
biht-305	25	54	with	with	ADP
biht-305	25	55	blockchain	blockchain	PROPN
biht-305	25	56	technology	technology	PROPN
biht-305	25	57	.	.	PUNCT
biht-305	26	1	the	the	DET
biht-305	26	2	2023	2023	NUM
biht-305	26	3	conference	conference	NOUN
biht-305	26	4	highlighted	highlight	VERB
biht-305	26	5	pivotal	pivotal	ADJ
biht-305	26	6	drivers	driver	NOUN
biht-305	26	7	accelerating	accelerate	VERB
biht-305	26	8	the	the	DET
biht-305	26	9	adoption	adoption	NOUN
biht-305	26	10	of	of	ADP
biht-305	26	11	blockchain	blockchain	PROPN
biht-305	26	12	solutions.6	solutions.6	PROPN
biht-305	26	13	during	during	ADP
biht-305	26	14	a	a	DET
biht-305	26	15	60	60	NUM
biht-305	26	16	-	-	PUNCT
biht-305	26	17	minute	minute	NOUN
biht-305	26	18	interactive	interactive	ADJ
biht-305	26	19	learning	learning	NOUN
biht-305	26	20	exercise	exercise	NOUN
biht-305	26	21	,	,	PUNCT
biht-305	26	22	a	a	DET
biht-305	26	23	convenience	convenience	NOUN
biht-305	26	24	sample	sample	NOUN
biht-305	26	25	of	of	ADP
biht-305	26	26	conference	conference	NOUN
biht-305	26	27	attendees	attendee	NOUN
biht-305	26	28	,	,	PUNCT
biht-305	26	29	primarily	primarily	ADV
biht-305	26	30	industry	industry	NOUN
biht-305	26	31	practitioners	practitioner	NOUN
biht-305	26	32	and	and	CCONJ
biht-305	26	33	experts	expert	NOUN
biht-305	26	34	,	,	PUNCT
biht-305	26	35	participated	participate	VERB
biht-305	26	36	in	in	ADP
biht-305	26	37	a	a	DET
biht-305	26	38	workgroup	workgroup	NOUN
biht-305	26	39	to	to	PART
biht-305	26	40	explore	explore	VERB
biht-305	26	41	considerations	consideration	NOUN
biht-305	26	42	related	relate	VERB
biht-305	26	43	to	to	ADP
biht-305	26	44	dct	dct	PROPN
biht-305	26	45	uptake	uptake	NOUN
biht-305	26	46	and	and	CCONJ
biht-305	26	47	delayed	delayed	ADJ
biht-305	26	48	diffusion	diffusion	NOUN
biht-305	26	49	of	of	ADP
biht-305	26	50	innovation	innovation	NOUN
biht-305	26	51	across	across	ADP
biht-305	26	52	key	key	ADJ
biht-305	26	53	stakeholders	stakeholder	NOUN
biht-305	26	54	.	.	PUNCT
biht-305	27	1	this	this	DET
biht-305	27	2	activity	activity	NOUN
biht-305	27	3	was	be	AUX
biht-305	27	4	completed	complete	VERB
biht-305	27	5	as	as	ADP
biht-305	27	6	part	part	NOUN
biht-305	27	7	of	of	ADP
biht-305	27	8	a	a	DET
biht-305	27	9	conference	conference	NOUN
biht-305	27	10	session	session	NOUN
biht-305	27	11	and	and	CCONJ
biht-305	27	12	was	be	AUX
biht-305	27	13	intended	intend	VERB
biht-305	27	14	for	for	ADP
biht-305	27	15	something	something	PRON
biht-305	27	16	other	other	ADJ
biht-305	27	17	than	than	ADP
biht-305	27	18	research	research	NOUN
biht-305	27	19	.	.	PUNCT
biht-305	28	1	attendees	attendee	NOUN
biht-305	28	2	voluntarily	voluntarily	ADV
biht-305	28	3	and	and	CCONJ
biht-305	28	4	anonymously	anonymously	ADV
biht-305	28	5	participated	participate	VERB
biht-305	28	6	,	,	PUNCT
biht-305	28	7	and	and	CCONJ
biht-305	28	8	no	no	DET
biht-305	28	9	identifying	identify	VERB
biht-305	28	10	information	information	NOUN
biht-305	28	11	was	be	AUX
biht-305	28	12	linked	link	VERB
biht-305	28	13	to	to	ADP
biht-305	28	14	responses	response	NOUN
biht-305	28	15	.	.	PUNCT
biht-305	29	1	furthermore	furthermore	ADV
biht-305	29	2	,	,	PUNCT
biht-305	29	3	opinions	opinion	NOUN
biht-305	29	4	were	be	AUX
biht-305	29	5	presented	present	VERB
biht-305	29	6	as	as	ADP
biht-305	29	7	group	group	NOUN
biht-305	29	8	consensus	consensus	NOUN
biht-305	29	9	and	and	CCONJ
biht-305	29	10	did	do	AUX
biht-305	29	11	not	not	PART
biht-305	29	12	include	include	VERB
biht-305	29	13	individual	individual	ADJ
biht-305	29	14	participant	participant	ADJ
biht-305	29	15	comments	comment	NOUN
biht-305	29	16	.	.	PUNCT
biht-305	30	1	prior	prior	ADV
biht-305	30	2	to	to	ADP
biht-305	30	3	the	the	DET
biht-305	30	4	assessment	assessment	NOUN
biht-305	30	5	,	,	PUNCT
biht-305	30	6	broad	broad	ADJ
biht-305	30	7	“	"	PUNCT
biht-305	30	8	pain	pain	NOUN
biht-305	30	9	points	point	NOUN
biht-305	30	10	”	"	PUNCT
biht-305	30	11	in	in	ADP
biht-305	30	12	existing	exist	VERB
biht-305	30	13	technology	technology	NOUN
biht-305	30	14	utilization	utilization	NOUN
biht-305	30	15	were	be	AUX
biht-305	30	16	presented	present	VERB
biht-305	30	17	.	.	PUNCT
biht-305	31	1	these	these	PRON
biht-305	31	2	included	include	VERB
biht-305	31	3	:	:	PUNCT
biht-305	32	1	1	1	X
biht-305	32	2	.	.	PUNCT
biht-305	32	3	the	the	DET
biht-305	32	4	lack	lack	NOUN
biht-305	32	5	of	of	ADP
biht-305	32	6	availability	availability	NOUN
biht-305	32	7	of	of	ADP
biht-305	32	8	real	real	ADJ
biht-305	32	9	-	-	PUNCT
biht-305	32	10	time	time	NOUN
biht-305	32	11	data	datum	NOUN
biht-305	32	12	driven	drive	VERB
biht-305	32	13	by	by	ADP
biht-305	32	14	substantially	substantially	ADV
biht-305	32	15	batch	batch	NOUN
biht-305	32	16	-	-	PUNCT
biht-305	32	17	driven	drive	VERB
biht-305	32	18	processes	process	NOUN
biht-305	32	19	;	;	PUNCT
biht-305	32	20	2	2	X
biht-305	32	21	.	.	X
biht-305	33	1	the	the	DET
biht-305	33	2	presence	presence	NOUN
biht-305	33	3	of	of	ADP
biht-305	33	4	multiple	multiple	ADJ
biht-305	33	5	systems	system	NOUN
biht-305	33	6	for	for	ADP
biht-305	33	7	various	various	ADJ
biht-305	33	8	parts	part	NOUN
biht-305	33	9	of	of	ADP
biht-305	33	10	the	the	DET
biht-305	33	11	processes	process	NOUN
biht-305	33	12	exacerbating	exacerbate	VERB
biht-305	33	13	inefficiencies	inefficiency	NOUN
biht-305	33	14	;	;	PUNCT
biht-305	33	15	3	3	X
biht-305	33	16	.	.	X
biht-305	33	17	the	the	DET
biht-305	33	18	need	need	NOUN
biht-305	33	19	for	for	ADP
biht-305	33	20	manual	manual	NOUN
biht-305	33	21	,	,	PUNCT
biht-305	33	22	risk	risk	NOUN
biht-305	33	23	-	-	PUNCT
biht-305	33	24	based	base	VERB
biht-305	33	25	monitoring	monitoring	NOUN
biht-305	33	26	and	and	CCONJ
biht-305	33	27	source	source	NOUN
biht-305	33	28	data	datum	NOUN
biht-305	33	29	verification	verification	NOUN
biht-305	33	30	as	as	ADP
biht-305	33	31	a	a	DET
biht-305	33	32	governance	governance	NOUN
biht-305	33	33	process	process	NOUN
biht-305	33	34	;	;	PUNCT
biht-305	33	35	4	4	X
biht-305	33	36	.	.	X
biht-305	34	1	the	the	DET
biht-305	34	2	presence	presence	NOUN
biht-305	34	3	of	of	ADP
biht-305	34	4	data	datum	NOUN
biht-305	34	5	integrity	integrity	NOUN
biht-305	34	6	issues	issue	NOUN
biht-305	34	7	;	;	PUNCT
biht-305	34	8	and	and	CCONJ
biht-305	34	9	finally	finally	ADV
biht-305	34	10	,	,	PUNCT
biht-305	34	11	5	5	X
biht-305	34	12	.	.	PUNCT
biht-305	35	1	the	the	DET
biht-305	35	2	disconnect	disconnect	NOUN
biht-305	35	3	between	between	ADP
biht-305	35	4	operational	operational	ADJ
biht-305	35	5	activity	activity	NOUN
biht-305	35	6	and	and	CCONJ
biht-305	35	7	delayed	delay	VERB
biht-305	35	8	payments	payment	NOUN
biht-305	35	9	to	to	PART
biht-305	35	10	study	study	VERB
biht-305	35	11	participants	participant	NOUN
biht-305	35	12	.	.	PUNCT
biht-305	36	1	additionally	additionally	ADV
biht-305	36	2	,	,	PUNCT
biht-305	36	3	a	a	DET
biht-305	36	4	representative	representative	NOUN
biht-305	36	5	from	from	ADP
biht-305	36	6	bloqcube	bloqcube	ADJ
biht-305	36	7	®	®	NOUN
biht-305	36	8	demonstrated	demonstrate	VERB
biht-305	36	9	an	an	DET
biht-305	36	10	innovative	innovative	ADJ
biht-305	36	11	approach	approach	NOUN
biht-305	36	12	that	that	PRON
biht-305	36	13	uses	use	VERB
biht-305	36	14	a	a	DET
biht-305	36	15	blockchain	blockchain	PROPN
biht-305	36	16	-	-	PUNCT
biht-305	36	17	anchored	anchor	VERB
biht-305	36	18	solution	solution	NOUN
biht-305	36	19	,	,	PUNCT
biht-305	36	20	executed	execute	VERB
biht-305	36	21	on	on	ADP
biht-305	36	22	an	an	DET
biht-305	36	23	ipad	ipad	NOUN
biht-305	36	24	and	and	CCONJ
biht-305	36	25	cloud	cloud	NOUN
biht-305	36	26	,	,	PUNCT
biht-305	36	27	to	to	PART
biht-305	36	28	fully	fully	ADV
biht-305	36	29	integrate	integrate	VERB
biht-305	36	30	and	and	CCONJ
biht-305	36	31	decentralize	decentralize	VERB
biht-305	36	32	trial	trial	NOUN
biht-305	36	33	management	management	NOUN
biht-305	36	34	activities	activity	NOUN
biht-305	36	35	remotely	remotely	ADV
biht-305	36	36	in	in	ADP
biht-305	36	37	real	real	ADJ
biht-305	36	38	-	-	PUNCT
biht-305	36	39	time	time	NOUN
biht-305	36	40	.	.	PUNCT
biht-305	37	1	after	after	ADP
biht-305	37	2	introductions	introduction	NOUN
biht-305	37	3	,	,	PUNCT
biht-305	37	4	the	the	DET
biht-305	37	5	participants	participant	NOUN
biht-305	37	6	were	be	AUX
biht-305	37	7	subdivided	subdivide	VERB
biht-305	37	8	into	into	ADP
biht-305	37	9	three	three	NUM
biht-305	37	10	stakeholder	stakeholder	NOUN
biht-305	37	11	groups	group	NOUN
biht-305	37	12	(	(	PUNCT
biht-305	37	13	table	table	NOUN
biht-305	37	14	1	1	NUM
biht-305	37	15	)	)	PUNCT
biht-305	37	16	.	.	PUNCT
biht-305	38	1	at	at	ADP
biht-305	38	2	the	the	DET
biht-305	38	3	center	center	NOUN
biht-305	38	4	of	of	ADP
biht-305	38	5	all	all	DET
biht-305	38	6	activity	activity	NOUN
biht-305	38	7	,	,	PUNCT
biht-305	38	8	patients	patient	NOUN
biht-305	38	9	were	be	AUX
biht-305	38	10	the	the	DET
biht-305	38	11	payers	payer	NOUN
biht-305	38	12	.	.	PUNCT
biht-305	39	1	they	they	PRON
biht-305	39	2	have	have	VERB
biht-305	39	3	a	a	DET
biht-305	39	4	balanced	balanced	ADJ
biht-305	39	5	role	role	NOUN
biht-305	39	6	in	in	ADP
biht-305	39	7	ensuring	ensure	VERB
biht-305	39	8	adequate	adequate	ADJ
biht-305	39	9	returns	return	NOUN
biht-305	39	10	for	for	ADP
biht-305	39	11	shareholders	shareholder	NOUN
biht-305	39	12	and	and	CCONJ
biht-305	39	13	reaching	reach	VERB
biht-305	39	14	intended	intended	ADJ
biht-305	39	15	users	user	NOUN
biht-305	39	16	.	.	PUNCT
biht-305	40	1	the	the	DET
biht-305	40	2	purpose	purpose	NOUN
biht-305	40	3	of	of	ADP
biht-305	40	4	the	the	DET
biht-305	40	5	small	small	ADJ
biht-305	40	6	group	group	NOUN
biht-305	40	7	discussions	discussion	NOUN
biht-305	40	8	was	be	AUX
biht-305	40	9	to	to	PART
biht-305	40	10	identify	identify	VERB
biht-305	40	11	(	(	PUNCT
biht-305	40	12	1	1	X
biht-305	40	13	)	)	PUNCT
biht-305	40	14	problem	problem	NOUN
biht-305	40	15	definitions	definition	NOUN
biht-305	40	16	,	,	PUNCT
biht-305	40	17	(	(	PUNCT
biht-305	40	18	2	2	X
biht-305	40	19	)	)	PUNCT
biht-305	40	20	potential	potential	ADJ
biht-305	40	21	solutions	solution	NOUN
biht-305	40	22	,	,	PUNCT
biht-305	40	23	and	and	CCONJ
biht-305	40	24	(	(	PUNCT
biht-305	40	25	3	3	X
biht-305	40	26	)	)	PUNCT
biht-305	40	27	value	value	NOUN
biht-305	40	28	across	across	ADP
biht-305	40	29	each	each	DET
biht-305	40	30	stakeholder	stakeholder	NOUN
biht-305	40	31	group	group	NOUN
biht-305	40	32	.	.	PUNCT
biht-305	41	1	after	after	ADP
biht-305	41	2	the	the	DET
biht-305	41	3	discussion	discussion	NOUN
biht-305	41	4	,	,	PUNCT
biht-305	41	5	the	the	DET
biht-305	41	6	participants	participant	NOUN
biht-305	41	7	reconvened	reconvene	VERB
biht-305	41	8	for	for	ADP
biht-305	41	9	presentations	presentation	NOUN
biht-305	41	10	by	by	ADP
biht-305	41	11	each	each	DET
biht-305	41	12	group	group	NOUN
biht-305	41	13	and	and	CCONJ
biht-305	41	14	an	an	DET
biht-305	41	15	overall	overall	ADJ
biht-305	41	16	discussion	discussion	NOUN
biht-305	41	17	.	.	PUNCT
biht-305	42	1	results	result	VERB
biht-305	42	2	patients	patient	NOUN
biht-305	42	3	the	the	DET
biht-305	42	4	participants	participant	NOUN
biht-305	42	5	noted	note	VERB
biht-305	42	6	current	current	ADJ
biht-305	42	7	challenges	challenge	NOUN
biht-305	42	8	patients	patient	NOUN
biht-305	42	9	encounter	encounter	VERB
biht-305	42	10	when	when	SCONJ
biht-305	42	11	participating	participate	VERB
biht-305	42	12	in	in	ADP
biht-305	42	13	classic	classic	ADJ
biht-305	42	14	clinical	clinical	ADJ
biht-305	42	15	trials	trial	NOUN
biht-305	42	16	,	,	PUNCT
biht-305	42	17	including	include	VERB
biht-305	42	18	travel	travel	NOUN
biht-305	42	19	times	time	NOUN
biht-305	42	20	to	to	ADP
biht-305	42	21	participating	participate	VERB
biht-305	42	22	sites	site	NOUN
biht-305	42	23	,	,	PUNCT
biht-305	42	24	a	a	DET
biht-305	42	25	lack	lack	NOUN
biht-305	42	26	of	of	ADP
biht-305	42	27	communication	communication	NOUN
biht-305	42	28	,	,	PUNCT
biht-305	42	29	delays	delay	NOUN
biht-305	42	30	in	in	ADP
biht-305	42	31	payments	payment	NOUN
biht-305	42	32	,	,	PUNCT
biht-305	42	33	and	and	CCONJ
biht-305	42	34	discomfort	discomfort	VERB
biht-305	42	35	with	with	ADP
biht-305	42	36	consent	consent	NOUN
biht-305	42	37	disclosures	disclosure	NOUN
biht-305	42	38	.	.	PUNCT
biht-305	43	1	furthermore	furthermore	ADV
biht-305	43	2	,	,	PUNCT
biht-305	43	3	ethical	ethical	ADJ
biht-305	43	4	dilemmas	dilemma	NOUN
biht-305	43	5	(	(	PUNCT
biht-305	43	6	e.g.	e.g.	ADV
biht-305	43	7	,	,	PUNCT
biht-305	43	8	access	access	NOUN
biht-305	43	9	,	,	PUNCT
biht-305	43	10	placebos	placebo	NOUN
biht-305	43	11	)	)	PUNCT
biht-305	43	12	were	be	AUX
biht-305	43	13	identified	identify	VERB
biht-305	43	14	,	,	PUNCT
biht-305	43	15	especially	especially	ADV
biht-305	43	16	in	in	ADP
biht-305	43	17	life	life	NOUN
biht-305	43	18	-	-	PUNCT
biht-305	43	19	saving	save	VERB
biht-305	43	20	drug	drug	NOUN
biht-305	43	21	trials	trial	NOUN
biht-305	43	22	.	.	PUNCT
biht-305	44	1	finally	finally	ADV
biht-305	44	2	,	,	PUNCT
biht-305	44	3	the	the	DET
biht-305	44	4	discomfort	discomfort	NOUN
biht-305	44	5	caused	cause	VERB
biht-305	44	6	by	by	ADP
biht-305	44	7	the	the	DET
biht-305	44	8	lack	lack	NOUN
biht-305	44	9	of	of	ADP
biht-305	44	10	transparency	transparency	NOUN
biht-305	44	11	and	and	CCONJ
biht-305	44	12	access	access	NOUN
biht-305	44	13	to	to	ADP
biht-305	44	14	the	the	DET
biht-305	44	15	study	study	NOUN
biht-305	44	16	results	result	NOUN
biht-305	44	17	can	can	AUX
biht-305	44	18	be	be	AUX
biht-305	44	19	problematic	problematic	ADJ
biht-305	44	20	.	.	PUNCT
biht-305	45	1	consensus	consensus	NOUN
biht-305	45	2	solutions	solution	NOUN
biht-305	45	3	that	that	PRON
biht-305	45	4	were	be	AUX
biht-305	45	5	identified	identify	VERB
biht-305	45	6	included	include	VERB
biht-305	45	7	true	true	ADJ
biht-305	45	8	decentralization	decentralization	NOUN
biht-305	45	9	and	and	CCONJ
biht-305	45	10	distributed	distribute	VERB
biht-305	45	11	ledger	ledger	NOUN
biht-305	45	12	technologies	technology	NOUN
biht-305	45	13	(	(	PUNCT
biht-305	45	14	e.g.	e.g.	ADV
biht-305	45	15	,	,	PUNCT
biht-305	45	16	blockchain	blockchain	NOUN
biht-305	45	17	and	and	CCONJ
biht-305	45	18	gamification	gamification	NOUN
biht-305	45	19	)	)	PUNCT
biht-305	45	20	to	to	PART
biht-305	45	21	improve	improve	VERB
biht-305	45	22	acceptance	acceptance	NOUN
biht-305	45	23	.	.	PUNCT
biht-305	46	1	patient	patient	NOUN
biht-305	46	2	-	-	PUNCT
biht-305	46	3	centric	centric	ADJ
biht-305	46	4	,	,	PUNCT
biht-305	46	5	remote	remote	ADJ
biht-305	46	6	systems	system	NOUN
biht-305	46	7	can	can	AUX
biht-305	46	8	facilitate	facilitate	VERB
biht-305	46	9	electronic	electronic	ADJ
biht-305	46	10	data	datum	NOUN
biht-305	46	11	collection	collection	NOUN
biht-305	46	12	remotely	remotely	ADV
biht-305	46	13	from	from	ADP
biht-305	46	14	the	the	DET
biht-305	46	15	patient	patient	NOUN
biht-305	46	16	’s	’s	PART
biht-305	46	17	location	location	NOUN
biht-305	46	18	.	.	PUNCT
biht-305	47	1	additionally	additionally	ADV
biht-305	47	2	,	,	PUNCT
biht-305	47	3	using	use	VERB
biht-305	47	4	digital	digital	ADJ
biht-305	47	5	companion	companion	NOUN
biht-305	47	6	coaches	coach	NOUN
biht-305	47	7	or	or	CCONJ
biht-305	47	8	advocates	advocate	NOUN
biht-305	47	9	may	may	AUX
biht-305	47	10	alleviate	alleviate	VERB
biht-305	47	11	concerns	concern	NOUN
biht-305	47	12	,	,	PUNCT
biht-305	47	13	and	and	CCONJ
biht-305	47	14	creating	create	VERB
biht-305	47	15	shared	share	VERB
biht-305	47	16	incentive	incentive	NOUN
biht-305	47	17	models	model	NOUN
biht-305	47	18	could	could	AUX
biht-305	47	19	also	also	ADV
biht-305	47	20	enhance	enhance	VERB
biht-305	47	21	participation	participation	NOUN
biht-305	47	22	while	while	SCONJ
biht-305	47	23	working	work	VERB
biht-305	47	24	within	within	ADP
biht-305	47	25	an	an	DET
biht-305	47	26	ethical	ethical	ADJ
biht-305	47	27	framework	framework	NOUN
biht-305	47	28	.	.	PUNCT
biht-305	48	1	regarding	regard	VERB
biht-305	48	2	value	value	NOUN
biht-305	48	3	,	,	PUNCT
biht-305	48	4	the	the	DET
biht-305	48	5	group	group	NOUN
biht-305	48	6	agreed	agree	VERB
biht-305	48	7	that	that	SCONJ
biht-305	48	8	this	this	PRON
biht-305	48	9	is	be	AUX
biht-305	48	10	a	a	DET
biht-305	48	11	complex	complex	ADJ
biht-305	48	12	challenge	challenge	NOUN
biht-305	48	13	.	.	PUNCT
biht-305	49	1	they	they	PRON
biht-305	49	2	concurred	concur	VERB
biht-305	49	3	that	that	SCONJ
biht-305	49	4	the	the	DET
biht-305	49	5	speed	speed	NOUN
biht-305	49	6	of	of	ADP
biht-305	49	7	the	the	DET
biht-305	49	8	trials	trial	NOUN
biht-305	49	9	and	and	CCONJ
biht-305	49	10	dissemination	dissemination	NOUN
biht-305	49	11	of	of	ADP
biht-305	49	12	approved	approve	VERB
biht-305	49	13	drugs	drug	NOUN
biht-305	49	14	could	could	AUX
biht-305	49	15	serve	serve	VERB
biht-305	49	16	as	as	ADP
biht-305	49	17	a	a	DET
biht-305	49	18	value	value	NOUN
biht-305	49	19	indicator	indicator	NOUN
biht-305	49	20	,	,	PUNCT
biht-305	49	21	assuming	assume	VERB
biht-305	49	22	other	other	ADJ
biht-305	49	23	quality	quality	NOUN
biht-305	49	24	parameters	parameter	NOUN
biht-305	49	25	are	be	AUX
biht-305	49	26	met	meet	VERB
biht-305	49	27	.	.	PUNCT
biht-305	50	1	payers	payer	NOUN
biht-305	50	2	the	the	DET
biht-305	50	3	participants	participant	NOUN
biht-305	50	4	noted	note	VERB
biht-305	50	5	that	that	SCONJ
biht-305	50	6	payers	payer	NOUN
biht-305	50	7	were	be	AUX
biht-305	50	8	likely	likely	ADV
biht-305	50	9	concerned	concerned	ADJ
biht-305	50	10	about	about	ADP
biht-305	50	11	cost	cost	NOUN
biht-305	50	12	containment	containment	NOUN
biht-305	50	13	and	and	CCONJ
biht-305	50	14	the	the	DET
biht-305	50	15	efficacy	efficacy	NOUN
biht-305	50	16	of	of	ADP
biht-305	50	17	new	new	ADJ
biht-305	50	18	drugs	drug	NOUN
biht-305	50	19	table	table	NOUN
biht-305	50	20	1	1	NUM
biht-305	50	21	.	.	PUNCT
biht-305	50	22	three	three	NUM
biht-305	50	23	stakeholder	stakeholder	NOUN
biht-305	50	24	groups	group	NOUN
biht-305	50	25	are	be	AUX
biht-305	50	26	involved	involve	VERB
biht-305	50	27	in	in	ADP
biht-305	50	28	the	the	DET
biht-305	50	29	challenges	challenge	NOUN
biht-305	50	30	that	that	PRON
biht-305	50	31	slow	slow	VERB
biht-305	50	32	the	the	DET
biht-305	50	33	diffusion	diffusion	NOUN
biht-305	50	34	of	of	ADP
biht-305	50	35	innovation	innovation	NOUN
biht-305	50	36	for	for	ADP
biht-305	50	37	dcts	dct	NOUN
biht-305	50	38	and	and	CCONJ
biht-305	50	39	capture	capture	VERB
biht-305	50	40	considerations	consideration	NOUN
biht-305	50	41	stakeholders	stakeholder	NOUN
biht-305	50	42	activities	activitie	VERB
biht-305	50	43	patients	patient	NOUN
biht-305	50	44	study	study	VERB
biht-305	50	45	subjects	subject	NOUN
biht-305	50	46	for	for	ADP
biht-305	50	47	clinical	clinical	ADJ
biht-305	50	48	trials	trial	NOUN
biht-305	50	49	who	who	PRON
biht-305	50	50	later	later	ADV
biht-305	50	51	become	become	VERB
biht-305	50	52	consumers	consumer	NOUN
biht-305	50	53	of	of	ADP
biht-305	50	54	the	the	DET
biht-305	50	55	product	product	NOUN
biht-305	50	56	.	.	PUNCT
biht-305	51	1	payers	payer	NOUN
biht-305	51	2	government	government	NOUN
biht-305	51	3	entities	entity	NOUN
biht-305	51	4	or	or	CCONJ
biht-305	51	5	health	health	NOUN
biht-305	51	6	insurance	insurance	NOUN
biht-305	51	7	providers	provider	NOUN
biht-305	51	8	assess	assess	VERB
biht-305	51	9	the	the	DET
biht-305	51	10	costs	cost	NOUN
biht-305	51	11	and	and	CCONJ
biht-305	51	12	benefits	benefit	NOUN
biht-305	51	13	of	of	ADP
biht-305	51	14	new	new	ADJ
biht-305	51	15	drugs	drug	NOUN
biht-305	51	16	.	.	PUNCT
biht-305	52	1	play	play	VERB
biht-305	52	2	a	a	DET
biht-305	52	3	key	key	ADJ
biht-305	52	4	role	role	NOUN
biht-305	52	5	in	in	ADP
biht-305	52	6	western	western	ADJ
biht-305	52	7	economies	economy	NOUN
biht-305	52	8	.	.	PUNCT
biht-305	53	1	pharmaceutical	pharmaceutical	NOUN
biht-305	53	2	sponsors	sponsor	NOUN
biht-305	53	3	creators	creator	NOUN
biht-305	53	4	and	and	CCONJ
biht-305	53	5	drivers	driver	NOUN
biht-305	53	6	of	of	ADP
biht-305	53	7	innovation	innovation	NOUN
biht-305	53	8	.	.	PUNCT
biht-305	54	1	dcts	dct	NOUN
biht-305	54	2	:	:	PUNCT
biht-305	54	3	decentralized	decentralize	VERB
biht-305	54	4	clinical	clinical	ADJ
biht-305	54	5	trials	trial	NOUN
biht-305	54	6	.	.	PUNCT
biht-305	55	1	https://doi.org/10.30953/bhty.v7.305	https://doi.org/10.30953/bhty.v7.305	NOUN
biht-305	55	2	citation	citation	NOUN
biht-305	55	3	:	:	PUNCT
biht-305	56	1	blockchain	blockchain	NOUN
biht-305	56	2	in	in	ADP
biht-305	56	3	healthcare	healthcare	NOUN
biht-305	56	4	today	today	NOUN
biht-305	56	5	2024	2024	NUM
biht-305	56	6	,	,	PUNCT
biht-305	56	7	7	7	NUM
biht-305	56	8	:	:	SYM
biht-305	56	9	305	305	NUM
biht-305	56	10	https://doi.org/10.30953/bhty.v7.305	https://doi.org/10.30953/bhty.v7.305	NOUN
biht-305	56	11	3	3	NUM
biht-305	56	12	(	(	PUNCT
biht-305	56	13	page	page	NOUN
biht-305	56	14	number	number	NOUN
biht-305	56	15	not	not	PART
biht-305	56	16	for	for	ADP
biht-305	56	17	citation	citation	NOUN
biht-305	56	18	purpose	purpose	NOUN
biht-305	56	19	)	)	PUNCT
biht-305	56	20	leveraging	leverage	VERB
biht-305	56	21	dctms	dctms	NOUN
biht-305	56	22	to	to	PART
biht-305	56	23	advance	advance	VERB
biht-305	56	24	science	science	NOUN
biht-305	56	25	compared	compare	VERB
biht-305	56	26	to	to	ADP
biht-305	56	27	current	current	ADJ
biht-305	56	28	treatments	treatment	NOUN
biht-305	56	29	or	or	CCONJ
biht-305	56	30	the	the	DET
biht-305	56	31	“	"	PUNCT
biht-305	56	32	gold	gold	NOUN
biht-305	56	33	standards	standard	NOUN
biht-305	56	34	.	.	PUNCT
biht-305	56	35	”	"	PUNCT
biht-305	57	1	additionally	additionally	ADV
biht-305	57	2	,	,	PUNCT
biht-305	57	3	because	because	SCONJ
biht-305	57	4	payers	payer	NOUN
biht-305	57	5	do	do	AUX
biht-305	57	6	not	not	PART
biht-305	57	7	fund	fund	VERB
biht-305	57	8	clinical	clinical	ADJ
biht-305	57	9	trials	trial	NOUN
biht-305	57	10	,	,	PUNCT
biht-305	57	11	there	there	PRON
biht-305	57	12	is	be	VERB
biht-305	57	13	a	a	DET
biht-305	57	14	level	level	NOUN
biht-305	57	15	of	of	ADP
biht-305	57	16	uncertainty	uncertainty	NOUN
biht-305	57	17	as	as	SCONJ
biht-305	57	18	they	they	PRON
biht-305	57	19	do	do	AUX
biht-305	57	20	not	not	PART
biht-305	57	21	control	control	VERB
biht-305	57	22	key	key	ADJ
biht-305	57	23	elements	element	NOUN
biht-305	57	24	and	and	CCONJ
biht-305	57	25	risk	risk	VERB
biht-305	57	26	a	a	DET
biht-305	57	27	study	study	NOUN
biht-305	57	28	population	population	NOUN
biht-305	57	29	that	that	PRON
biht-305	57	30	is	be	AUX
biht-305	57	31	disparate	disparate	ADJ
biht-305	57	32	from	from	ADP
biht-305	57	33	the	the	DET
biht-305	57	34	populations	population	NOUN
biht-305	57	35	they	they	PRON
biht-305	57	36	serve	serve	VERB
biht-305	57	37	.	.	PUNCT
biht-305	58	1	there	there	PRON
biht-305	58	2	was	be	VERB
biht-305	58	3	consensus	consensus	NOUN
biht-305	58	4	among	among	ADP
biht-305	58	5	participants	participant	NOUN
biht-305	58	6	that	that	SCONJ
biht-305	58	7	one	one	NUM
biht-305	58	8	solution	solution	NOUN
biht-305	58	9	is	be	AUX
biht-305	58	10	value	value	NOUN
biht-305	58	11	-	-	PUNCT
biht-305	58	12	based	base	VERB
biht-305	58	13	contracting	contracting	NOUN
biht-305	58	14	,	,	PUNCT
biht-305	58	15	where	where	SCONJ
biht-305	58	16	costs	cost	NOUN
biht-305	58	17	are	be	AUX
biht-305	58	18	tied	tie	VERB
biht-305	58	19	to	to	ADP
biht-305	58	20	results	result	NOUN
biht-305	58	21	.	.	PUNCT
biht-305	59	1	other	other	ADJ
biht-305	59	2	solutions	solution	NOUN
biht-305	59	3	may	may	AUX
biht-305	59	4	include	include	VERB
biht-305	59	5	phase	phase	NOUN
biht-305	59	6	four	four	NUM
biht-305	59	7	studies	study	NOUN
biht-305	59	8	to	to	PART
biht-305	59	9	assess	assess	VERB
biht-305	59	10	long	long	ADJ
biht-305	59	11	-	-	PUNCT
biht-305	59	12	term	term	NOUN
biht-305	59	13	risks	risk	NOUN
biht-305	59	14	/	/	SYM
biht-305	59	15	benefits	benefit	NOUN
biht-305	59	16	and	and	CCONJ
biht-305	59	17	smart	smart	ADJ
biht-305	59	18	contracts	contract	NOUN
biht-305	59	19	to	to	PART
biht-305	59	20	automate	automate	VERB
biht-305	59	21	inefficient	inefficient	ADJ
biht-305	59	22	processes	process	NOUN
biht-305	59	23	.	.	PUNCT
biht-305	60	1	efforts	effort	NOUN
biht-305	60	2	to	to	PART
biht-305	60	3	cut	cut	VERB
biht-305	60	4	costs	cost	NOUN
biht-305	60	5	could	could	AUX
biht-305	60	6	be	be	AUX
biht-305	60	7	achieved	achieve	VERB
biht-305	60	8	by	by	ADP
biht-305	60	9	placing	place	VERB
biht-305	60	10	greater	great	ADJ
biht-305	60	11	emphasis	emphasis	NOUN
biht-305	60	12	on	on	ADP
biht-305	60	13	remote	remote	ADJ
biht-305	60	14	monitoring	monitoring	NOUN
biht-305	60	15	rather	rather	ADV
biht-305	60	16	than	than	ADP
biht-305	60	17	current	current	ADJ
biht-305	60	18	approaches	approach	NOUN
biht-305	60	19	.	.	PUNCT
biht-305	61	1	value	value	NOUN
biht-305	61	2	can	can	AUX
biht-305	61	3	be	be	AUX
biht-305	61	4	improved	improve	VERB
biht-305	61	5	by	by	ADP
biht-305	61	6	allocating	allocate	VERB
biht-305	61	7	more	more	ADJ
biht-305	61	8	funds	fund	NOUN
biht-305	61	9	to	to	ADP
biht-305	61	10	more	more	ADV
biht-305	61	11	effective	effective	ADJ
biht-305	61	12	drugs	drug	NOUN
biht-305	61	13	and	and	CCONJ
biht-305	61	14	using	use	VERB
biht-305	61	15	more	more	ADV
biht-305	61	16	efficient	efficient	ADJ
biht-305	61	17	processes	process	NOUN
biht-305	61	18	.	.	PUNCT
biht-305	62	1	pharmaceutical	pharmaceutical	NOUN
biht-305	62	2	sponsors	sponsor	NOUN
biht-305	62	3	first	first	ADV
biht-305	62	4	,	,	PUNCT
biht-305	62	5	participants	participant	NOUN
biht-305	62	6	emphasized	emphasize	VERB
biht-305	62	7	that	that	SCONJ
biht-305	62	8	a	a	DET
biht-305	62	9	primary	primary	ADJ
biht-305	62	10	goal	goal	NOUN
biht-305	62	11	for	for	ADP
biht-305	62	12	pharmaceutical	pharmaceutical	ADJ
biht-305	62	13	sponsors	sponsor	NOUN
biht-305	62	14	includes	include	VERB
biht-305	62	15	driving	drive	VERB
biht-305	62	16	innovation	innovation	NOUN
biht-305	62	17	for	for	ADP
biht-305	62	18	fast	fast	ADJ
biht-305	62	19	drug	drug	NOUN
biht-305	62	20	development	development	NOUN
biht-305	62	21	(	(	PUNCT
biht-305	62	22	e.g.	e.g.	ADV
biht-305	62	23	,	,	PUNCT
biht-305	62	24	covid-19	covid-19	PROPN
biht-305	62	25	vaccines	vaccine	NOUN
biht-305	62	26	)	)	PUNCT
biht-305	62	27	.	.	PUNCT
biht-305	63	1	related	relate	VERB
biht-305	63	2	issues	issue	NOUN
biht-305	63	3	include	include	VERB
biht-305	63	4	the	the	DET
biht-305	63	5	cost	cost	NOUN
biht-305	63	6	of	of	ADP
biht-305	63	7	drug	drug	NOUN
biht-305	63	8	development	development	NOUN
biht-305	63	9	,	,	PUNCT
biht-305	63	10	the	the	DET
biht-305	63	11	regulatory	regulatory	ADJ
biht-305	63	12	processes	process	NOUN
biht-305	63	13	for	for	ADP
biht-305	63	14	approval	approval	NOUN
biht-305	63	15	,	,	PUNCT
biht-305	63	16	and	and	CCONJ
biht-305	63	17	data	datum	NOUN
biht-305	63	18	security	security	NOUN
biht-305	63	19	.	.	PUNCT
biht-305	64	1	the	the	DET
biht-305	64	2	group	group	NOUN
biht-305	64	3	also	also	ADV
biht-305	64	4	emphasized	emphasize	VERB
biht-305	64	5	the	the	DET
biht-305	64	6	pivotal	pivotal	ADJ
biht-305	64	7	role	role	NOUN
biht-305	64	8	and	and	CCONJ
biht-305	64	9	the	the	DET
biht-305	64	10	need	need	NOUN
biht-305	64	11	to	to	PART
biht-305	64	12	protect	protect	VERB
biht-305	64	13	intellectual	intellectual	ADJ
biht-305	64	14	property	property	NOUN
biht-305	64	15	in	in	ADP
biht-305	64	16	drug	drug	NOUN
biht-305	64	17	development	development	NOUN
biht-305	64	18	,	,	PUNCT
biht-305	64	19	which	which	PRON
biht-305	64	20	is	be	AUX
biht-305	64	21	crucial	crucial	ADJ
biht-305	64	22	to	to	ADP
biht-305	64	23	original	original	ADJ
biht-305	64	24	inventions	invention	NOUN
biht-305	64	25	.	.	PUNCT
biht-305	65	1	participants	participant	NOUN
biht-305	65	2	highlighted	highlight	VERB
biht-305	65	3	the	the	DET
biht-305	65	4	need	need	NOUN
biht-305	65	5	for	for	ADP
biht-305	65	6	solutions	solution	NOUN
biht-305	65	7	such	such	ADJ
biht-305	65	8	as	as	ADP
biht-305	65	9	dcts	dct	NOUN
biht-305	65	10	for	for	ADP
biht-305	65	11	patient	patient	ADJ
biht-305	65	12	recruitment	recruitment	NOUN
biht-305	65	13	,	,	PUNCT
biht-305	65	14	ethically	ethically	ADV
biht-305	65	15	leveraging	leverage	VERB
biht-305	65	16	monetary	monetary	ADJ
biht-305	65	17	incentives	incentive	NOUN
biht-305	65	18	,	,	PUNCT
biht-305	65	19	and	and	CCONJ
biht-305	65	20	ensuring	ensure	VERB
biht-305	65	21	data	datum	NOUN
biht-305	65	22	integrity	integrity	NOUN
biht-305	65	23	.	.	PUNCT
biht-305	66	1	another	another	DET
biht-305	66	2	idea	idea	NOUN
biht-305	66	3	expressed	express	VERB
biht-305	66	4	was	be	AUX
biht-305	66	5	to	to	PART
biht-305	66	6	share	share	VERB
biht-305	66	7	negative	negative	ADJ
biht-305	66	8	results	result	NOUN
biht-305	66	9	to	to	PART
biht-305	66	10	facilitate	facilitate	VERB
biht-305	66	11	learning	learn	VERB
biht-305	66	12	science	science	NOUN
biht-305	66	13	.	.	PUNCT
biht-305	67	1	participants	participant	NOUN
biht-305	67	2	agreed	agree	VERB
biht-305	67	3	that	that	SCONJ
biht-305	67	4	a	a	DET
biht-305	67	5	smooth	smooth	ADJ
biht-305	67	6	process	process	NOUN
biht-305	67	7	is	be	AUX
biht-305	67	8	critical	critical	ADJ
biht-305	67	9	.	.	PUNCT
biht-305	68	1	cloud	cloud	NOUN
biht-305	68	2	-	-	PUNCT
biht-305	68	3	based	base	VERB
biht-305	68	4	systems	system	NOUN
biht-305	68	5	combined	combine	VERB
biht-305	68	6	with	with	ADP
biht-305	68	7	blockchain	blockchain	PROPN
biht-305	68	8	and	and	CCONJ
biht-305	68	9	cryptographic	cryptographic	ADJ
biht-305	68	10	security	security	NOUN
biht-305	68	11	can	can	AUX
biht-305	68	12	provide	provide	VERB
biht-305	68	13	a	a	DET
biht-305	68	14	seamless	seamless	ADJ
biht-305	68	15	flow	flow	NOUN
biht-305	68	16	of	of	ADP
biht-305	68	17	compliant	compliant	ADJ
biht-305	68	18	data	datum	NOUN
biht-305	68	19	while	while	SCONJ
biht-305	68	20	minimizing	minimize	VERB
biht-305	68	21	the	the	DET
biht-305	68	22	vulnerability	vulnerability	NOUN
biht-305	68	23	to	to	PART
biht-305	68	24	ransomware	ransomware	NOUN
biht-305	68	25	attacks	attack	NOUN
biht-305	68	26	.	.	PUNCT
biht-305	69	1	value	value	VERB
biht-305	69	2	an	an	DET
biht-305	69	3	alternative	alternative	ADJ
biht-305	69	4	definition	definition	NOUN
biht-305	69	5	of	of	ADP
biht-305	69	6	“	"	PUNCT
biht-305	69	7	value	value	NOUN
biht-305	69	8	”	"	PUNCT
biht-305	69	9	often	often	ADV
biht-305	69	10	used	use	VERB
biht-305	69	11	in	in	ADP
biht-305	69	12	healthcare	healthcare	NOUN
biht-305	69	13	is	be	AUX
biht-305	69	14	quality	quality	NOUN
biht-305	69	15	divided	divide	VERB
biht-305	69	16	by	by	ADP
biht-305	69	17	cost	cost	NOUN
biht-305	69	18	.	.	PUNCT
biht-305	70	1	the	the	DET
biht-305	70	2	participants	participant	NOUN
biht-305	70	3	agreed	agree	VERB
biht-305	70	4	that	that	SCONJ
biht-305	70	5	cost	cost	NOUN
biht-305	70	6	often	often	ADV
biht-305	70	7	becomes	become	VERB
biht-305	70	8	a	a	DET
biht-305	70	9	primary	primary	ADJ
biht-305	70	10	focus	focus	NOUN
biht-305	70	11	,	,	PUNCT
biht-305	70	12	as	as	SCONJ
biht-305	70	13	it	it	PRON
biht-305	70	14	is	be	AUX
biht-305	70	15	easily	easily	ADV
biht-305	70	16	measured	measure	VERB
biht-305	70	17	.	.	PUNCT
biht-305	71	1	however	however	ADV
biht-305	71	2	,	,	PUNCT
biht-305	71	3	it	it	PRON
biht-305	71	4	has	have	VERB
biht-305	71	5	a	a	DET
biht-305	71	6	natural	natural	ADJ
biht-305	71	7	limit	limit	NOUN
biht-305	71	8	on	on	ADP
biht-305	71	9	the	the	DET
biht-305	71	10	extent	extent	NOUN
biht-305	71	11	of	of	ADP
biht-305	71	12	value	value	NOUN
biht-305	71	13	.	.	PUNCT
biht-305	72	1	if	if	SCONJ
biht-305	72	2	the	the	DET
biht-305	72	3	primary	primary	ADJ
biht-305	72	4	focus	focus	NOUN
biht-305	72	5	shifts	shift	NOUN
biht-305	72	6	to	to	ADP
biht-305	72	7	quality	quality	NOUN
biht-305	72	8	instead	instead	ADV
biht-305	72	9	of	of	ADP
biht-305	72	10	cost	cost	NOUN
biht-305	72	11	,	,	PUNCT
biht-305	72	12	there	there	PRON
biht-305	72	13	is	be	VERB
biht-305	72	14	greater	great	ADJ
biht-305	72	15	latitude	latitude	NOUN
biht-305	72	16	for	for	ADP
biht-305	72	17	significant	significant	ADJ
biht-305	72	18	value	value	NOUN
biht-305	72	19	gains	gain	NOUN
biht-305	72	20	.	.	PUNCT
biht-305	73	1	it	it	PRON
biht-305	73	2	is	be	AUX
biht-305	73	3	important	important	ADJ
biht-305	73	4	to	to	PART
biht-305	73	5	track	track	VERB
biht-305	73	6	and	and	CCONJ
biht-305	73	7	manage	manage	VERB
biht-305	73	8	different	different	ADJ
biht-305	73	9	stakeholder	stakeholder	NOUN
biht-305	73	10	perspectives	perspective	NOUN
biht-305	73	11	to	to	PART
biht-305	73	12	ensure	ensure	VERB
biht-305	73	13	that	that	SCONJ
biht-305	73	14	innovative	innovative	ADJ
biht-305	73	15	solutions	solution	NOUN
biht-305	73	16	are	be	AUX
biht-305	73	17	well	well	ADV
biht-305	73	18	accepted	accept	VERB
biht-305	73	19	and	and	CCONJ
biht-305	73	20	absorbed	absorb	VERB
biht-305	73	21	.	.	PUNCT
biht-305	74	1	discussion	discussion	NOUN
biht-305	74	2	while	while	SCONJ
biht-305	74	3	dcts	dct	NOUN
biht-305	74	4	are	be	AUX
biht-305	74	5	a	a	DET
biht-305	74	6	worthy	worthy	ADJ
biht-305	74	7	end	end	NOUN
biht-305	74	8	goal	goal	NOUN
biht-305	74	9	,	,	PUNCT
biht-305	74	10	the	the	DET
biht-305	74	11	true	true	ADJ
biht-305	74	12	worth	worth	NOUN
biht-305	74	13	is	be	AUX
biht-305	74	14	the	the	DET
biht-305	74	15	ability	ability	NOUN
biht-305	74	16	to	to	PART
biht-305	74	17	engage	engage	VERB
biht-305	74	18	study	study	NOUN
biht-305	74	19	subjects	subject	NOUN
biht-305	74	20	at	at	ADP
biht-305	74	21	a	a	DET
biht-305	74	22	level	level	NOUN
biht-305	74	23	of	of	ADP
biht-305	74	24	multiples	multiple	NOUN
biht-305	74	25	of	of	ADP
biht-305	74	26	growth	growth	NOUN
biht-305	74	27	with	with	ADP
biht-305	74	28	a	a	DET
biht-305	74	29	resulting	result	VERB
biht-305	74	30	improvement	improvement	NOUN
biht-305	74	31	in	in	ADP
biht-305	74	32	drug	drug	NOUN
biht-305	74	33	development	development	NOUN
biht-305	74	34	in	in	ADP
biht-305	74	35	many	many	ADJ
biht-305	74	36	areas	area	NOUN
biht-305	74	37	.	.	PUNCT
biht-305	75	1	participants	participant	NOUN
biht-305	75	2	shared	share	VERB
biht-305	75	3	potential	potential	ADJ
biht-305	75	4	problems	problem	NOUN
biht-305	75	5	and	and	CCONJ
biht-305	75	6	solutions	solution	NOUN
biht-305	75	7	within	within	ADP
biht-305	75	8	multiple	multiple	ADJ
biht-305	75	9	stakeholder	stakeholder	NOUN
biht-305	75	10	groups	group	NOUN
biht-305	75	11	.	.	PUNCT
biht-305	76	1	several	several	ADJ
biht-305	76	2	themes	theme	NOUN
biht-305	76	3	that	that	PRON
biht-305	76	4	can	can	AUX
biht-305	76	5	be	be	AUX
biht-305	76	6	supported	support	VERB
biht-305	76	7	by	by	ADP
biht-305	76	8	blockchain	blockchain	PROPN
biht-305	76	9	technology	technology	PROPN
biht-305	76	10	emerged	emerge	VERB
biht-305	76	11	across	across	ADP
biht-305	76	12	all	all	DET
biht-305	76	13	three	three	NUM
biht-305	76	14	stakeholder	stakeholder	NOUN
biht-305	76	15	groups	group	NOUN
biht-305	76	16	.	.	PUNCT
biht-305	77	1	consistent	consistent	ADJ
biht-305	77	2	with	with	ADP
biht-305	77	3	current	current	ADJ
biht-305	77	4	literature,7,8	literature,7,8	NOUN
biht-305	77	5	these	these	DET
biht-305	77	6	themes	theme	NOUN
biht-305	77	7	included	include	VERB
biht-305	77	8	enhanced	enhanced	ADJ
biht-305	77	9	efficiencies	efficiency	NOUN
biht-305	77	10	,	,	PUNCT
biht-305	77	11	patient	patient	ADJ
biht-305	77	12	experience	experience	NOUN
biht-305	77	13	/	/	SYM
biht-305	77	14	demographic	demographic	ADJ
biht-305	77	15	diversity	diversity	NOUN
biht-305	77	16	,	,	PUNCT
biht-305	77	17	data	datum	NOUN
biht-305	77	18	integrity	integrity	NOUN
biht-305	77	19	/	/	SYM
biht-305	77	20	privacy	privacy	NOUN
biht-305	77	21	/	/	SYM
biht-305	77	22	security	security	NOUN
biht-305	77	23	,	,	PUNCT
biht-305	77	24	and	and	CCONJ
biht-305	77	25	cost	cost	NOUN
biht-305	77	26	-	-	PUNCT
biht-305	77	27	effectiveness	effectiveness	NOUN
biht-305	77	28	.	.	PUNCT
biht-305	78	1	improved	improve	VERB
biht-305	78	2	efficiencies	efficiency	NOUN
biht-305	78	3	were	be	AUX
biht-305	78	4	suggested	suggest	VERB
biht-305	78	5	with	with	ADP
biht-305	78	6	regulatory	regulatory	ADJ
biht-305	78	7	practice	practice	NOUN
biht-305	78	8	automation	automation	NOUN
biht-305	78	9	and	and	CCONJ
biht-305	78	10	risk	risk	NOUN
biht-305	78	11	-	-	PUNCT
biht-305	78	12	based	base	VERB
biht-305	78	13	monitoring	monitoring	NOUN
biht-305	78	14	.	.	PUNCT
biht-305	79	1	in	in	ADP
biht-305	79	2	a	a	DET
biht-305	79	3	recent	recent	ADJ
biht-305	79	4	report	report	NOUN
biht-305	79	5	,	,	PUNCT
biht-305	79	6	mckinsey	mckinsey	NOUN
biht-305	79	7	&	&	CCONJ
biht-305	79	8	company	company	PROPN
biht-305	79	9	suggested	suggest	VERB
biht-305	79	10	that	that	SCONJ
biht-305	79	11	the	the	DET
biht-305	79	12	greatest	great	ADJ
biht-305	79	13	opportunity	opportunity	NOUN
biht-305	79	14	for	for	SCONJ
biht-305	79	15	sponsors	sponsor	NOUN
biht-305	79	16	to	to	PART
biht-305	79	17	accelerate	accelerate	VERB
biht-305	79	18	clinical	clinical	ADJ
biht-305	79	19	trials	trial	NOUN
biht-305	79	20	is	be	AUX
biht-305	79	21	to	to	PART
biht-305	79	22	increase	increase	VERB
biht-305	79	23	the	the	DET
biht-305	79	24	speed	speed	NOUN
biht-305	79	25	and	and	CCONJ
biht-305	79	26	improve	improve	VERB
biht-305	79	27	the	the	DET
biht-305	79	28	efficiency	efficiency	NOUN
biht-305	79	29	of	of	ADP
biht-305	79	30	clinical	clinical	ADJ
biht-305	79	31	trial	trial	NOUN
biht-305	79	32	enrollment.9	enrollment.9	PROPN
biht-305	79	33	these	these	DET
biht-305	79	34	improvements	improvement	NOUN
biht-305	79	35	will	will	AUX
biht-305	79	36	benefit	benefit	VERB
biht-305	79	37	patients	patient	NOUN
biht-305	79	38	,	,	PUNCT
biht-305	79	39	payers	payer	NOUN
biht-305	79	40	,	,	PUNCT
biht-305	79	41	and	and	CCONJ
biht-305	79	42	pharmaceutical	pharmaceutical	NOUN
biht-305	79	43	companies	company	NOUN
biht-305	79	44	.	.	PUNCT
biht-305	80	1	additionally	additionally	ADV
biht-305	80	2	,	,	PUNCT
biht-305	80	3	using	use	VERB
biht-305	80	4	decentralized	decentralized	ADJ
biht-305	80	5	models	model	NOUN
biht-305	80	6	can	can	AUX
biht-305	80	7	foster	foster	VERB
biht-305	80	8	a	a	DET
biht-305	80	9	more	more	ADV
biht-305	80	10	robust	robust	ADJ
biht-305	80	11	study	study	NOUN
biht-305	80	12	population	population	NOUN
biht-305	80	13	and	and	CCONJ
biht-305	80	14	meet	meet	VERB
biht-305	80	15	the	the	DET
biht-305	80	16	needs	need	NOUN
biht-305	80	17	of	of	ADP
biht-305	80	18	many	many	ADJ
biht-305	80	19	patients	patient	NOUN
biht-305	80	20	with	with	ADP
biht-305	80	21	a	a	DET
biht-305	80	22	disease	disease	NOUN
biht-305	80	23	with	with	ADP
biht-305	80	24	no	no	DET
biht-305	80	25	known	know	VERB
biht-305	80	26	therapies.9	therapies.9	NOUN
biht-305	80	27	of	of	ADP
biht-305	80	28	equal	equal	ADJ
biht-305	80	29	importance	importance	NOUN
biht-305	80	30	are	be	AUX
biht-305	80	31	data	datum	NOUN
biht-305	80	32	integrity	integrity	NOUN
biht-305	80	33	,	,	PUNCT
biht-305	80	34	security	security	NOUN
biht-305	80	35	,	,	PUNCT
biht-305	80	36	and	and	CCONJ
biht-305	80	37	privacy	privacy	NOUN
biht-305	80	38	,	,	PUNCT
biht-305	80	39	which	which	PRON
biht-305	80	40	promote	promote	VERB
biht-305	80	41	patient	patient	ADJ
biht-305	80	42	comfort	comfort	NOUN
biht-305	80	43	and	and	CCONJ
biht-305	80	44	fidelity	fidelity	NOUN
biht-305	80	45	in	in	ADP
biht-305	80	46	clinical	clinical	ADJ
biht-305	80	47	trials	trial	NOUN
biht-305	80	48	.	.	PUNCT
biht-305	81	1	blockchain	blockchain	PROPN
biht-305	81	2	technology	technology	PROPN
biht-305	81	3	streamlines	streamline	VERB
biht-305	81	4	monetary	monetary	ADJ
biht-305	81	5	exchange	exchange	NOUN
biht-305	81	6	by	by	ADP
biht-305	81	7	removing	remove	VERB
biht-305	81	8	the	the	DET
biht-305	81	9	need	need	NOUN
biht-305	81	10	for	for	SCONJ
biht-305	81	11	intermediaries	intermediary	NOUN
biht-305	81	12	to	to	PART
biht-305	81	13	complete	complete	VERB
biht-305	81	14	transactions	transaction	NOUN
biht-305	81	15	faster	fast	ADV
biht-305	81	16	and	and	CCONJ
biht-305	81	17	more	more	ADV
biht-305	81	18	efficiently	efficiently	ADV
biht-305	81	19	.	.	PUNCT
biht-305	82	1	managing	manage	VERB
biht-305	82	2	trial	trial	NOUN
biht-305	82	3	subject	subject	NOUN
biht-305	82	4	consents	consent	NOUN
biht-305	82	5	and	and	CCONJ
biht-305	82	6	clinical	clinical	ADJ
biht-305	82	7	trials	trial	NOUN
biht-305	82	8	is	be	AUX
biht-305	82	9	an	an	DET
biht-305	82	10	area	area	NOUN
biht-305	82	11	in	in	ADP
biht-305	82	12	which	which	PRON
biht-305	82	13	blockchain	blockchain	NOUN
biht-305	82	14	can	can	AUX
biht-305	82	15	improve	improve	VERB
biht-305	82	16	the	the	DET
biht-305	82	17	efficiency	efficiency	NOUN
biht-305	82	18	,	,	PUNCT
biht-305	82	19	accountability	accountability	NOUN
biht-305	82	20	,	,	PUNCT
biht-305	82	21	audit	audit	NOUN
biht-305	82	22	ability	ability	NOUN
biht-305	82	23	,	,	PUNCT
biht-305	82	24	and	and	CCONJ
biht-305	82	25	transparency	transparency	NOUN
biht-305	82	26	of	of	ADP
biht-305	82	27	researchers	researcher	NOUN
biht-305	82	28	and	and	CCONJ
biht-305	82	29	practitioners	practitioner	NOUN
biht-305	82	30	in	in	ADP
biht-305	82	31	healthcare	healthcare	PROPN
biht-305	82	32	.	.	PUNCT
biht-305	83	1	data	datum	NOUN
biht-305	83	2	also	also	ADV
biht-305	83	3	suggests	suggest	VERB
biht-305	83	4	that	that	SCONJ
biht-305	83	5	blockchain	blockchain	PROPN
biht-305	83	6	technology	technology	NOUN
biht-305	83	7	reduces	reduce	VERB
biht-305	83	8	monitoring	monitoring	NOUN
biht-305	83	9	visit	visit	NOUN
biht-305	83	10	time	time	NOUN
biht-305	83	11	and	and	CCONJ
biht-305	83	12	cost	cost	NOUN
biht-305	83	13	while	while	SCONJ
biht-305	83	14	improving	improve	VERB
biht-305	83	15	patient	patient	ADJ
biht-305	83	16	trust	trust	NOUN
biht-305	83	17	and	and	CCONJ
biht-305	83	18	sense	sense	NOUN
biht-305	83	19	of	of	ADP
biht-305	83	20	empowerment	empowerment	NOUN
biht-305	83	21	compared	compare	VERB
biht-305	83	22	to	to	ADP
biht-305	83	23	conventional	conventional	ADJ
biht-305	83	24	clinical	clinical	ADJ
biht-305	83	25	trial	trial	NOUN
biht-305	83	26	management.10	management.10	NOUN
biht-305	83	27	while	while	SCONJ
biht-305	83	28	many	many	ADJ
biht-305	83	29	key	key	ADJ
biht-305	83	30	insights	insight	NOUN
biht-305	83	31	supporting	support	VERB
biht-305	83	32	blockchain	blockchain	PROPN
biht-305	83	33	technology	technology	PROPN
biht-305	83	34	were	be	AUX
biht-305	83	35	explored	explore	VERB
biht-305	83	36	and	and	CCONJ
biht-305	83	37	supported	support	VERB
biht-305	83	38	,	,	PUNCT
biht-305	83	39	several	several	ADJ
biht-305	83	40	points	point	NOUN
biht-305	83	41	of	of	ADP
biht-305	83	42	consideration	consideration	NOUN
biht-305	83	43	,	,	PUNCT
biht-305	83	44	not	not	PART
biht-305	83	45	widely	widely	ADV
biht-305	83	46	discussed	discuss	VERB
biht-305	83	47	during	during	ADP
biht-305	83	48	the	the	DET
biht-305	83	49	session	session	NOUN
biht-305	83	50	,	,	PUNCT
biht-305	83	51	include	include	VERB
biht-305	83	52	the	the	DET
biht-305	83	53	appropriateness	appropriateness	NOUN
biht-305	83	54	of	of	ADP
biht-305	83	55	use	use	NOUN
biht-305	83	56	,	,	PUNCT
biht-305	83	57	regulatory	regulatory	ADJ
biht-305	83	58	standards	standard	NOUN
biht-305	83	59	,	,	PUNCT
biht-305	83	60	and	and	CCONJ
biht-305	83	61	data	datum	NOUN
biht-305	83	62	privacy	privacy	NOUN
biht-305	83	63	.	.	PUNCT
biht-305	84	1	blockchain	blockchain	PROPN
biht-305	84	2	technology	technology	PROPN
biht-305	84	3	offers	offer	VERB
biht-305	84	4	solutions	solution	NOUN
biht-305	84	5	to	to	ADP
biht-305	84	6	several	several	ADJ
biht-305	84	7	challenges	challenge	NOUN
biht-305	84	8	identified	identify	VERB
biht-305	84	9	by	by	ADP
biht-305	84	10	the	the	DET
biht-305	84	11	participants	participant	NOUN
biht-305	84	12	;	;	PUNCT
biht-305	84	13	however	however	ADV
biht-305	84	14	,	,	PUNCT
biht-305	84	15	it	it	PRON
biht-305	84	16	is	be	AUX
biht-305	84	17	not	not	PART
biht-305	84	18	always	always	ADV
biht-305	84	19	the	the	DET
biht-305	84	20	best	good	ADJ
biht-305	84	21	solution.1,4	solution.1,4	ADJ
biht-305	84	22	guidance	guidance	NOUN
biht-305	84	23	on	on	ADP
biht-305	84	24	when	when	SCONJ
biht-305	84	25	and	and	CCONJ
biht-305	84	26	when	when	SCONJ
biht-305	84	27	not	not	PART
biht-305	84	28	to	to	PART
biht-305	84	29	use	use	VERB
biht-305	84	30	blockchain	blockchain	PROPN
biht-305	84	31	-	-	PUNCT
biht-305	84	32	based	base	VERB
biht-305	84	33	solutions	solution	NOUN
biht-305	84	34	is	be	AUX
biht-305	84	35	readily	readily	ADV
biht-305	84	36	available	available	ADJ
biht-305	84	37	(	(	PUNCT
biht-305	84	38	figure	figure	NOUN
biht-305	84	39	1	1	NUM
biht-305	84	40	)	)	PUNCT
biht-305	84	41	.	.	PUNCT
biht-305	85	1	additionally	additionally	ADV
biht-305	85	2	,	,	PUNCT
biht-305	85	3	the	the	DET
biht-305	85	4	decentralized	decentralize	VERB
biht-305	85	5	trials	trial	NOUN
biht-305	85	6	&	&	CCONJ
biht-305	85	7	research	research	PROPN
biht-305	85	8	alliance	alliance	NOUN
biht-305	85	9	(	(	PUNCT
biht-305	85	10	dtra	dtra	PROPN
biht-305	85	11	)	)	PUNCT
biht-305	85	12	developed	develop	VERB
biht-305	85	13	a	a	DET
biht-305	85	14	rubric	rubric	NOUN
biht-305	85	15	to	to	PART
biht-305	85	16	provide	provide	VERB
biht-305	85	17	a	a	DET
biht-305	85	18	consistent	consistent	ADJ
biht-305	85	19	framework	framework	NOUN
biht-305	85	20	when	when	SCONJ
biht-305	85	21	evaluating	evaluate	VERB
biht-305	85	22	the	the	DET
biht-305	85	23	evidence	evidence	NOUN
biht-305	85	24	of	of	ADP
biht-305	85	25	success	success	NOUN
biht-305	85	26	,	,	PUNCT
biht-305	85	27	patient	patient	ADJ
biht-305	85	28	experience	experience	NOUN
biht-305	85	29	,	,	PUNCT
biht-305	85	30	site	site	NOUN
biht-305	85	31	impact	impact	NOUN
biht-305	85	32	,	,	PUNCT
biht-305	85	33	operational	operational	ADJ
biht-305	85	34	and	and	CCONJ
biht-305	85	35	technical	technical	ADJ
biht-305	85	36	feasibility	feasibility	NOUN
biht-305	85	37	,	,	PUNCT
biht-305	85	38	and	and	CCONJ
biht-305	85	39	regulatory	regulatory	ADJ
biht-305	85	40	and	and	CCONJ
biht-305	85	41	ethical	ethical	ADJ
biht-305	85	42	compliance.11	compliance.11	PROPN
biht-305	85	43	furthermore	furthermore	ADV
biht-305	85	44	,	,	PUNCT
biht-305	85	45	the	the	DET
biht-305	85	46	fda	fda	PROPN
biht-305	85	47	has	have	AUX
biht-305	85	48	published	publish	VERB
biht-305	85	49	draft	draft	NOUN
biht-305	85	50	guidance	guidance	NOUN
biht-305	85	51	on	on	ADP
biht-305	85	52	decentralized	decentralize	VERB
biht-305	85	53	trials	trial	NOUN
biht-305	85	54	,	,	PUNCT
biht-305	85	55	and	and	CCONJ
biht-305	85	56	it	it	PRON
biht-305	85	57	is	be	AUX
biht-305	85	58	recognized	recognize	VERB
biht-305	85	59	that	that	SCONJ
biht-305	85	60	many	many	ADJ
biht-305	85	61	clinical	clinical	ADJ
biht-305	85	62	trials	trial	NOUN
biht-305	85	63	already	already	ADV
biht-305	85	64	include	include	VERB
biht-305	85	65	decentralized	decentralize	VERB
biht-305	85	66	elements.1,12	elements.1,12	PROPN
biht-305	85	67	a	a	DET
biht-305	85	68	dct	dct	PROPN
biht-305	85	69	,	,	PUNCT
biht-305	85	70	when	when	SCONJ
biht-305	85	71	performed	perform	VERB
biht-305	85	72	at	at	ADP
biht-305	85	73	a	a	DET
biht-305	85	74	patient	patient	NOUN
biht-305	85	75	’s	’s	PART
biht-305	85	76	home	home	NOUN
biht-305	85	77	,	,	PUNCT
biht-305	85	78	requires	require	VERB
biht-305	85	79	additional	additional	ADJ
biht-305	85	80	safeguards	safeguard	NOUN
biht-305	85	81	from	from	ADP
biht-305	85	82	a	a	DET
biht-305	85	83	data	data	NOUN
biht-305	85	84	privacy	privacy	NOUN
biht-305	85	85	governance	governance	NOUN
biht-305	85	86	given	give	VERB
biht-305	85	87	the	the	DET
biht-305	85	88	health	health	NOUN
biht-305	85	89	insurance	insurance	NOUN
biht-305	85	90	portability	portability	NOUN
biht-305	85	91	and	and	CCONJ
biht-305	85	92	accountability	accountability	NOUN
biht-305	85	93	act	act	NOUN
biht-305	85	94	(	(	PUNCT
biht-305	85	95	hipaa	hipaa	PROPN
biht-305	85	96	)	)	PUNCT
biht-305	85	97	,	,	PUNCT
biht-305	85	98	the	the	DET
biht-305	85	99	general	general	ADJ
biht-305	85	100	data	data	PROPN
biht-305	85	101	protection	protection	NOUN
biht-305	85	102	regulation	regulation	NOUN
biht-305	85	103	(	(	PUNCT
biht-305	85	104	gdpr	gdpr	NOUN
biht-305	85	105	)	)	PUNCT
biht-305	85	106	,	,	PUNCT
biht-305	85	107	and	and	CCONJ
biht-305	85	108	similar	similar	ADJ
biht-305	85	109	legislation	legislation	NOUN
biht-305	85	110	.	.	PUNCT
biht-305	86	1	the	the	DET
biht-305	86	2	fda	fda	PROPN
biht-305	86	3	regulatory	regulatory	ADJ
biht-305	86	4	requirements	requirement	NOUN
biht-305	86	5	are	be	AUX
biht-305	86	6	the	the	DET
biht-305	86	7	same	same	ADJ
biht-305	86	8	for	for	ADP
biht-305	86	9	dcts	dct	NOUN
biht-305	86	10	and	and	CCONJ
biht-305	86	11	traditional	traditional	ADJ
biht-305	86	12	sitebased	sitebase	VERB
biht-305	86	13	clinical	clinical	ADJ
biht-305	86	14	trials.12	trials.12	NOUN
biht-305	86	15	while	while	SCONJ
biht-305	86	16	blockchain	blockchain	PROPN
biht-305	86	17	,	,	PUNCT
biht-305	86	18	known	know	VERB
biht-305	86	19	for	for	ADP
biht-305	86	20	its	its	PRON
biht-305	86	21	robustness	robustness	NOUN
biht-305	86	22	and	and	CCONJ
biht-305	86	23	transparency	transparency	NOUN
biht-305	86	24	,	,	PUNCT
biht-305	86	25	may	may	AUX
biht-305	86	26	inherently	inherently	ADV
biht-305	86	27	pose	pose	VERB
biht-305	86	28	unique	unique	ADJ
biht-305	86	29	challenges	challenge	NOUN
biht-305	86	30	in	in	ADP
biht-305	86	31	maintaining	maintain	VERB
biht-305	86	32	data	data	NOUN
biht-305	86	33	privacy	privacy	NOUN
biht-305	86	34	and	and	CCONJ
biht-305	86	35	complying	comply	VERB
biht-305	86	36	with	with	ADP
biht-305	86	37	security	security	NOUN
biht-305	86	38	standards	standard	NOUN
biht-305	86	39	,	,	PUNCT
biht-305	86	40	capturing	capture	VERB
biht-305	86	41	data	datum	NOUN
biht-305	86	42	and	and	CCONJ
biht-305	86	43	working	work	VERB
biht-305	86	44	with	with	ADP
biht-305	86	45	it	it	PRON
biht-305	86	46	using	use	VERB
biht-305	86	47	paper	paper	NOUN
biht-305	86	48	is	be	AUX
biht-305	86	49	sub	sub	ADJ
biht-305	86	50	-	-	ADJ
biht-305	86	51	optimal.13	optimal.13	NOUN
biht-305	86	52	in	in	ADP
biht-305	86	53	the	the	DET
biht-305	86	54	rapidly	rapidly	ADV
biht-305	86	55	evolving	evolve	VERB
biht-305	86	56	world	world	NOUN
biht-305	86	57	of	of	ADP
biht-305	86	58	blockchain	blockchain	PROPN
biht-305	86	59	technology	technology	PROPN
biht-305	86	60	,	,	PUNCT
biht-305	86	61	privacy	privacy	NOUN
biht-305	86	62	and	and	CCONJ
biht-305	86	63	security	security	NOUN
biht-305	86	64	remain	remain	VERB
biht-305	86	65	at	at	ADP
biht-305	86	66	the	the	DET
biht-305	86	67	forefront.13	forefront.13	PROPN
biht-305	86	68	a	a	DET
biht-305	86	69	blockchain	blockchain	PROPN
biht-305	86	70	-	-	PUNCT
biht-305	86	71	driven	drive	VERB
biht-305	86	72	data	datum	NOUN
biht-305	86	73	https://doi.org/10.30953/bhty.v7.305	https://doi.org/10.30953/bhty.v7.305	NOUN
biht-305	86	74	citation	citation	NOUN
biht-305	86	75	:	:	PUNCT
biht-305	87	1	blockchain	blockchain	NOUN
biht-305	87	2	in	in	ADP
biht-305	87	3	healthcare	healthcare	NOUN
biht-305	87	4	today	today	NOUN
biht-305	87	5	2024	2024	NUM
biht-305	87	6	,	,	PUNCT
biht-305	87	7	7	7	NUM
biht-305	87	8	:	:	SYM
biht-305	87	9	305	305	NUM
biht-305	87	10	https://doi.org/10.30953/bhty.v7.305	https://doi.org/10.30953/bhty.v7.305	NOUN
biht-305	87	11	4	4	NUM
biht-305	87	12	(	(	PUNCT
biht-305	87	13	page	page	NOUN
biht-305	87	14	number	number	NOUN
biht-305	87	15	not	not	PART
biht-305	87	16	for	for	ADP
biht-305	87	17	citation	citation	NOUN
biht-305	87	18	purpose	purpose	NOUN
biht-305	87	19	)	)	PUNCT
biht-305	87	20	rama	rama	PROPN
biht-305	87	21	krishna	krishna	PROPN
biht-305	87	22	rao	rao	PROPN
biht-305	87	23	protection	protection	NOUN
biht-305	87	24	solution	solution	NOUN
biht-305	87	25	permits	permit	VERB
biht-305	87	26	a	a	DET
biht-305	87	27	high	high	ADJ
biht-305	87	28	level	level	NOUN
biht-305	87	29	of	of	ADP
biht-305	87	30	confidentiality	confidentiality	NOUN
biht-305	87	31	for	for	ADP
biht-305	87	32	patients	patient	NOUN
biht-305	87	33	’	'	PUNCT
biht-305	87	34	records	record	NOUN
biht-305	87	35	/	/	SYM
biht-305	87	36	data	datum	NOUN
biht-305	87	37	.	.	PUNCT
biht-305	88	1	this	this	DET
biht-305	88	2	exercise	exercise	NOUN
biht-305	88	3	has	have	VERB
biht-305	88	4	several	several	ADJ
biht-305	88	5	limitations	limitation	NOUN
biht-305	88	6	.	.	PUNCT
biht-305	89	1	first	first	ADV
biht-305	89	2	,	,	PUNCT
biht-305	89	3	the	the	DET
biht-305	89	4	focus	focus	NOUN
biht-305	89	5	groups	group	NOUN
biht-305	89	6	consisted	consist	VERB
biht-305	89	7	of	of	ADP
biht-305	89	8	a	a	DET
biht-305	89	9	convenience	convenience	NOUN
biht-305	89	10	sample	sample	NOUN
biht-305	89	11	of	of	ADP
biht-305	89	12	conference	conference	NOUN
biht-305	89	13	participants	participant	NOUN
biht-305	89	14	.	.	PUNCT
biht-305	90	1	additionally	additionally	ADV
biht-305	90	2	,	,	PUNCT
biht-305	90	3	the	the	DET
biht-305	90	4	presentation	presentation	NOUN
biht-305	90	5	and	and	CCONJ
biht-305	90	6	discussions	discussion	NOUN
biht-305	90	7	were	be	AUX
biht-305	90	8	completed	complete	VERB
biht-305	90	9	within	within	ADP
biht-305	90	10	a	a	DET
biht-305	90	11	limited	limited	ADJ
biht-305	90	12	amount	amount	NOUN
biht-305	90	13	of	of	ADP
biht-305	90	14	time	time	NOUN
biht-305	90	15	.	.	PUNCT
biht-305	91	1	lastly	lastly	ADV
biht-305	91	2	,	,	PUNCT
biht-305	91	3	it	it	PRON
biht-305	91	4	must	must	AUX
biht-305	91	5	be	be	AUX
biht-305	91	6	noted	note	VERB
biht-305	91	7	that	that	SCONJ
biht-305	91	8	the	the	DET
biht-305	91	9	areas	area	NOUN
biht-305	91	10	of	of	ADP
biht-305	91	11	discussion	discussion	NOUN
biht-305	91	12	represent	represent	VERB
biht-305	91	13	a	a	DET
biht-305	91	14	small	small	ADJ
biht-305	91	15	overview	overview	NOUN
biht-305	91	16	of	of	ADP
biht-305	91	17	the	the	DET
biht-305	91	18	canvas	canvas	NOUN
biht-305	91	19	of	of	ADP
biht-305	91	20	options	option	NOUN
biht-305	91	21	for	for	ADP
biht-305	91	22	clinical	clinical	ADJ
biht-305	91	23	trial	trial	NOUN
biht-305	91	24	systems	system	NOUN
biht-305	91	25	.	.	PUNCT
biht-305	92	1	conclusion	conclusion	NOUN
biht-305	92	2	key	key	ADJ
biht-305	92	3	stakeholders	stakeholder	NOUN
biht-305	92	4	offer	offer	VERB
biht-305	92	5	a	a	DET
biht-305	92	6	unique	unique	ADJ
biht-305	92	7	perspective	perspective	NOUN
biht-305	92	8	that	that	PRON
biht-305	92	9	can	can	AUX
biht-305	92	10	leverage	leverage	VERB
biht-305	92	11	current	current	ADJ
biht-305	92	12	technologies	technology	NOUN
biht-305	92	13	and	and	CCONJ
biht-305	92	14	facilitate	facilitate	VERB
biht-305	92	15	the	the	DET
biht-305	92	16	adoption	adoption	NOUN
biht-305	92	17	of	of	ADP
biht-305	92	18	truly	truly	ADV
biht-305	92	19	decentralized	decentralize	VERB
biht-305	92	20	clinical	clinical	ADJ
biht-305	92	21	trial	trial	NOUN
biht-305	92	22	management	management	NOUN
biht-305	92	23	systems	system	NOUN
biht-305	92	24	(	(	PUNCT
biht-305	92	25	dms	dms	PROPN
biht-305	92	26	)	)	PUNCT
biht-305	92	27	.	.	PUNCT
biht-305	93	1	additional	additional	ADJ
biht-305	93	2	research	research	NOUN
biht-305	93	3	is	be	AUX
biht-305	93	4	needed	need	VERB
biht-305	93	5	to	to	PART
biht-305	93	6	facilitate	facilitate	VERB
biht-305	93	7	the	the	DET
biht-305	93	8	pervasive	pervasive	ADJ
biht-305	93	9	implementation	implementation	NOUN
biht-305	93	10	of	of	ADP
biht-305	93	11	blockchain	blockchain	PROPN
biht-305	93	12	technology	technology	PROPN
biht-305	93	13	and	and	CCONJ
biht-305	93	14	address	address	NOUN
biht-305	93	15	challenges	challenge	NOUN
biht-305	93	16	related	relate	VERB
biht-305	93	17	to	to	ADP
biht-305	93	18	health	health	NOUN
biht-305	93	19	diagnostics	diagnostic	NOUN
biht-305	93	20	,	,	PUNCT
biht-305	93	21	patient	patient	ADJ
biht-305	93	22	care	care	NOUN
biht-305	93	23	processes	process	NOUN
biht-305	93	24	in	in	ADP
biht-305	93	25	remote	remote	ADJ
biht-305	93	26	monitoring	monitoring	NOUN
biht-305	93	27	or	or	CCONJ
biht-305	93	28	emergencies	emergency	NOUN
biht-305	93	29	,	,	PUNCT
biht-305	93	30	data	datum	NOUN
biht-305	93	31	integrity	integrity	NOUN
biht-305	93	32	,	,	PUNCT
biht-305	93	33	and	and	CCONJ
biht-305	93	34	fraud	fraud	NOUN
biht-305	93	35	avoidance.7	avoidance.7	PROPN
biht-305	93	36	despite	despite	SCONJ
biht-305	93	37	the	the	DET
biht-305	93	38	promising	promising	ADJ
biht-305	93	39	value	value	NOUN
biht-305	93	40	proposition	proposition	NOUN
biht-305	93	41	of	of	ADP
biht-305	93	42	blockchain	blockchain	PROPN
biht-305	93	43	technology	technology	PROPN
biht-305	93	44	in	in	ADP
biht-305	93	45	clinical	clinical	ADJ
biht-305	93	46	trials	trial	NOUN
biht-305	93	47	,	,	PUNCT
biht-305	93	48	broad	broad	ADJ
biht-305	93	49	adoption	adoption	NOUN
biht-305	93	50	will	will	AUX
biht-305	93	51	require	require	VERB
biht-305	93	52	the	the	DET
biht-305	93	53	industry	industry	NOUN
biht-305	93	54	to	to	PART
biht-305	93	55	overcome	overcome	VERB
biht-305	93	56	technological	technological	ADJ
biht-305	93	57	barriers.10	barriers.10	NOUN
biht-305	93	58	future	future	ADJ
biht-305	93	59	research	research	NOUN
biht-305	93	60	may	may	AUX
biht-305	93	61	include	include	VERB
biht-305	93	62	additional	additional	ADJ
biht-305	93	63	stakeholders	stakeholder	NOUN
biht-305	93	64	,	,	PUNCT
biht-305	93	65	such	such	ADJ
biht-305	93	66	as	as	ADP
biht-305	93	67	researchers	researcher	NOUN
biht-305	93	68	,	,	PUNCT
biht-305	93	69	regulators	regulator	NOUN
biht-305	93	70	,	,	PUNCT
biht-305	93	71	healthcare	healthcare	NOUN
biht-305	93	72	providers	provider	NOUN
biht-305	93	73	,	,	PUNCT
biht-305	93	74	and	and	CCONJ
biht-305	93	75	others	other	NOUN
biht-305	93	76	involved	involve	VERB
biht-305	93	77	in	in	ADP
biht-305	93	78	clinical	clinical	ADJ
biht-305	93	79	trials	trial	NOUN
biht-305	93	80	who	who	PRON
biht-305	93	81	may	may	AUX
biht-305	93	82	not	not	PART
biht-305	93	83	be	be	AUX
biht-305	93	84	familiar	familiar	ADJ
biht-305	93	85	with	with	ADP
biht-305	93	86	this	this	DET
biht-305	93	87	technology	technology	NOUN
biht-305	93	88	.	.	PUNCT
biht-305	94	1	the	the	DET
biht-305	94	2	dcts	dct	NOUN
biht-305	94	3	are	be	AUX
biht-305	94	4	a	a	DET
biht-305	94	5	promising	promising	ADJ
biht-305	94	6	approach	approach	NOUN
biht-305	94	7	to	to	PART
biht-305	94	8	improve	improve	VERB
biht-305	94	9	the	the	DET
biht-305	94	10	efficiency	efficiency	NOUN
biht-305	94	11	,	,	PUNCT
biht-305	94	12	patient	patient	ADJ
biht-305	94	13	experience	experience	NOUN
biht-305	94	14	,	,	PUNCT
biht-305	94	15	demographic	demographic	ADJ
biht-305	94	16	diversity	diversity	NOUN
biht-305	94	17	,	,	PUNCT
biht-305	94	18	and	and	CCONJ
biht-305	94	19	cost	cost	NOUN
biht-305	94	20	-	-	PUNCT
biht-305	94	21	effectiveness	effectiveness	NOUN
biht-305	94	22	of	of	ADP
biht-305	94	23	clinical	clinical	ADJ
biht-305	94	24	research.3,8	research.3,8	PROPN
biht-305	94	25	this	this	DET
biht-305	94	26	exercise	exercise	NOUN
biht-305	94	27	explored	explore	VERB
biht-305	94	28	how	how	SCONJ
biht-305	94	29	blockchain	blockchain	PROPN
biht-305	94	30	technology	technology	PROPN
biht-305	94	31	and	and	CCONJ
biht-305	94	32	decentralized	decentralize	VERB
biht-305	94	33	clinical	clinical	ADJ
biht-305	94	34	trial	trial	NOUN
biht-305	94	35	management	management	NOUN
biht-305	94	36	systems	system	NOUN
biht-305	94	37	(	(	PUNCT
biht-305	94	38	dctms	dctms	PROPN
biht-305	94	39	)	)	PUNCT
biht-305	94	40	can	can	AUX
biht-305	94	41	positively	positively	ADV
biht-305	94	42	impact	impact	VERB
biht-305	94	43	patients	patient	NOUN
biht-305	94	44	,	,	PUNCT
biht-305	94	45	payers	payer	NOUN
biht-305	94	46	,	,	PUNCT
biht-305	94	47	and	and	CCONJ
biht-305	94	48	pharmaceutical	pharmaceutical	NOUN
biht-305	94	49	sponsors	sponsor	NOUN
biht-305	94	50	by	by	ADP
biht-305	94	51	improving	improve	VERB
biht-305	94	52	efficiencies	efficiency	NOUN
biht-305	94	53	,	,	PUNCT
biht-305	94	54	patient	patient	ADJ
biht-305	94	55	experiences	experience	NOUN
biht-305	94	56	,	,	PUNCT
biht-305	94	57	demographic	demographic	ADJ
biht-305	94	58	diversity	diversity	NOUN
biht-305	94	59	,	,	PUNCT
biht-305	94	60	data	datum	NOUN
biht-305	94	61	management	management	NOUN
biht-305	94	62	,	,	PUNCT
biht-305	94	63	and	and	CCONJ
biht-305	94	64	cost	cost	NOUN
biht-305	94	65	effectiveness	effectiveness	NOUN
biht-305	94	66	.	.	PUNCT
biht-305	95	1	although	although	SCONJ
biht-305	95	2	several	several	ADJ
biht-305	95	3	solutions	solution	NOUN
biht-305	95	4	have	have	AUX
biht-305	95	5	been	be	AUX
biht-305	95	6	developed	develop	VERB
biht-305	95	7	,	,	PUNCT
biht-305	95	8	challenges	challenge	NOUN
biht-305	95	9	with	with	ADP
biht-305	95	10	adoption	adoption	NOUN
biht-305	95	11	still	still	ADV
biht-305	95	12	need	need	VERB
biht-305	95	13	to	to	PART
biht-305	95	14	be	be	AUX
biht-305	95	15	addressed	address	VERB
biht-305	95	16	.	.	PUNCT
biht-305	96	1	the	the	DET
biht-305	96	2	diffusion	diffusion	NOUN
biht-305	96	3	of	of	ADP
biht-305	96	4	blockchain	blockchain	PROPN
biht-305	96	5	technology	technology	PROPN
biht-305	96	6	is	be	AUX
biht-305	96	7	highly	highly	ADV
biht-305	96	8	applicable	applicable	ADJ
biht-305	96	9	and	and	CCONJ
biht-305	96	10	can	can	AUX
biht-305	96	11	reshape	reshape	VERB
biht-305	96	12	the	the	DET
biht-305	96	13	future	future	NOUN
biht-305	96	14	of	of	ADP
biht-305	96	15	healthcare	healthcare	NOUN
biht-305	96	16	by	by	ADP
biht-305	96	17	increasing	increase	VERB
biht-305	96	18	study	study	NOUN
biht-305	96	19	participation	participation	NOUN
biht-305	96	20	in	in	ADP
biht-305	96	21	clinical	clinical	ADJ
biht-305	96	22	trials	trial	NOUN
biht-305	96	23	;	;	PUNCT
biht-305	96	24	however	however	ADV
biht-305	96	25	,	,	PUNCT
biht-305	96	26	understanding	understanding	NOUN
biht-305	96	27	and	and	CCONJ
biht-305	96	28	overcoming	overcome	VERB
biht-305	96	29	the	the	DET
biht-305	96	30	challenges	challenge	NOUN
biht-305	96	31	of	of	ADP
biht-305	96	32	adoption	adoption	NOUN
biht-305	96	33	is	be	AUX
biht-305	96	34	essential	essential	ADJ
biht-305	96	35	.	.	PUNCT
biht-305	97	1	funding	fund	VERB
biht-305	97	2	none	none	NOUN
biht-305	97	3	.	.	PUNCT
biht-305	98	1	financial	financial	ADJ
biht-305	98	2	and	and	CCONJ
biht-305	98	3	non	non	ADJ
biht-305	98	4	-	-	ADJ
biht-305	98	5	financial	financial	ADJ
biht-305	98	6	relationships	relationship	NOUN
biht-305	98	7	and	and	CCONJ
biht-305	98	8	activities	activity	NOUN
biht-305	98	9	the	the	DET
biht-305	98	10	author	author	NOUN
biht-305	98	11	declares	declare	VERB
biht-305	98	12	the	the	DET
biht-305	98	13	following	follow	VERB
biht-305	98	14	competing	compete	VERB
biht-305	98	15	financial	financial	ADJ
biht-305	98	16	interest	interest	NOUN
biht-305	98	17	.	.	PUNCT
biht-305	99	1	the	the	DET
biht-305	99	2	author	author	NOUN
biht-305	99	3	holds	hold	VERB
biht-305	99	4	equity	equity	NOUN
biht-305	99	5	ownership	ownership	NOUN
biht-305	99	6	in	in	ADP
biht-305	99	7	bloqcube	bloqcube	ADJ
biht-305	99	8	®	®	PROPN
biht-305	99	9	.	.	PUNCT
biht-305	100	1	contributor	contributor	PROPN
biht-305	100	2	rama	rama	PROPN
biht-305	100	3	krishna	krishna	PROPN
biht-305	100	4	rao	rao	PROPN
biht-305	100	5	independently	independently	ADV
biht-305	100	6	chaired	chair	VERB
biht-305	100	7	and	and	CCONJ
biht-305	100	8	facilitated	facilitate	VERB
biht-305	100	9	the	the	DET
biht-305	100	10	interactive	interactive	ADJ
biht-305	100	11	learning	learning	NOUN
biht-305	100	12	session	session	NOUN
biht-305	100	13	,	,	PUNCT
biht-305	100	14	workgroups	workgroup	NOUN
biht-305	100	15	,	,	PUNCT
biht-305	100	16	and	and	CCONJ
biht-305	100	17	all	all	DET
biht-305	100	18	products	product	NOUN
biht-305	100	19	resulting	result	VERB
biht-305	100	20	from	from	ADP
biht-305	100	21	the	the	DET
biht-305	100	22	discussions	discussion	NOUN
biht-305	100	23	.	.	PUNCT
biht-305	101	1	data	datum	NOUN
biht-305	101	2	availability	availability	NOUN
biht-305	101	3	statement	statement	NOUN
biht-305	101	4	(	(	PUNCT
biht-305	101	5	das	das	PROPN
biht-305	101	6	)	)	PUNCT
biht-305	101	7	,	,	PUNCT
biht-305	101	8	data	datum	NOUN
biht-305	101	9	sharing	sharing	NOUN
biht-305	101	10	,	,	PUNCT
biht-305	101	11	reproducibility	reproducibility	NOUN
biht-305	101	12	,	,	PUNCT
biht-305	101	13	and	and	CCONJ
biht-305	101	14	data	datum	NOUN
biht-305	101	15	repositories	repository	NOUN
biht-305	101	16	original	original	ADJ
biht-305	101	17	data	datum	NOUN
biht-305	101	18	were	be	AUX
biht-305	101	19	not	not	PART
biht-305	101	20	generated	generate	VERB
biht-305	101	21	for	for	ADP
biht-305	101	22	this	this	DET
biht-305	101	23	editorial	editorial	NOUN
biht-305	101	24	.	.	PUNCT
biht-305	102	1	application	application	NOUN
biht-305	102	2	of	of	ADP
biht-305	102	3	ai	ai	ADJ
biht-305	102	4	-	-	PUNCT
biht-305	102	5	generated	generate	VERB
biht-305	102	6	text	text	NOUN
biht-305	102	7	or	or	CCONJ
biht-305	102	8	related	related	ADJ
biht-305	102	9	technology	technology	NOUN
biht-305	102	10	none	none	NOUN
biht-305	102	11	applied	apply	VERB
biht-305	102	12	.	.	PUNCT
biht-305	103	1	fig	fig	NOUN
biht-305	103	2	.	.	PUNCT
biht-305	104	1	1	1	NUM
biht-305	104	2	.	.	X
biht-305	104	3	when	when	SCONJ
biht-305	104	4	should	should	AUX
biht-305	104	5	we	we	PRON
biht-305	104	6	use	use	VERB
biht-305	104	7	a	a	DET
biht-305	104	8	blockchain	blockchain	NOUN
biht-305	104	9	solution	solution	NOUN
biht-305	104	10	and	and	CCONJ
biht-305	104	11	when	when	SCONJ
biht-305	104	12	not	not	PART
biht-305	104	13	to	to	PART
biht-305	104	14	.	.	PUNCT
biht-305	105	1	https://doi.org/10.30953/bhty.v7.305	https://doi.org/10.30953/bhty.v7.305	NOUN
biht-305	105	2	citation	citation	NOUN
biht-305	105	3	:	:	PUNCT
biht-305	106	1	blockchain	blockchain	NOUN
biht-305	106	2	in	in	ADP
biht-305	106	3	healthcare	healthcare	NOUN
biht-305	106	4	today	today	NOUN
biht-305	106	5	2024	2024	NUM
biht-305	106	6	,	,	PUNCT
biht-305	106	7	7	7	NUM
biht-305	106	8	:	:	SYM
biht-305	106	9	305	305	NUM
biht-305	106	10	https://doi.org/10.30953/bhty.v7.305	https://doi.org/10.30953/bhty.v7.305	NOUN
biht-305	106	11	5	5	NUM
biht-305	106	12	(	(	PUNCT
biht-305	106	13	page	page	NOUN
biht-305	106	14	number	number	NOUN
biht-305	106	15	not	not	PART
biht-305	106	16	for	for	ADP
biht-305	106	17	citation	citation	NOUN
biht-305	106	18	purpose	purpose	NOUN
biht-305	106	19	)	)	PUNCT
biht-305	106	20	leveraging	leverage	VERB
biht-305	106	21	dctms	dctms	NOUN
biht-305	106	22	to	to	PART
biht-305	106	23	advance	advance	VERB
biht-305	106	24	science	science	NOUN
biht-305	106	25	acknowledgments	acknowledgment	NOUN
biht-305	106	26	the	the	DET
biht-305	106	27	author	author	NOUN
biht-305	106	28	thanks	thank	NOUN
biht-305	106	29	the	the	DET
biht-305	106	30	conference	conference	NOUN
biht-305	106	31	attendees	attendee	NOUN
biht-305	106	32	who	who	PRON
biht-305	106	33	participated	participate	VERB
biht-305	106	34	in	in	ADP
biht-305	106	35	the	the	DET
biht-305	106	36	learning	learning	NOUN
biht-305	106	37	session	session	NOUN
biht-305	106	38	and	and	CCONJ
biht-305	106	39	workgroups	workgroup	NOUN
biht-305	106	40	.	.	PUNCT
biht-305	107	1	references	reference	NOUN
biht-305	107	2	1	1	NUM
biht-305	107	3	.	.	PUNCT
biht-305	107	4	food	food	NOUN
biht-305	107	5	and	and	CCONJ
biht-305	107	6	drug	drug	NOUN
biht-305	107	7	administration	administration	NOUN
biht-305	107	8	.	.	PUNCT
biht-305	108	1	the	the	DET
biht-305	108	2	evolving	evolve	VERB
biht-305	108	3	role	role	NOUN
biht-305	108	4	of	of	ADP
biht-305	108	5	decentralized	decentralize	VERB
biht-305	108	6	clinical	clinical	ADJ
biht-305	108	7	trials	trial	NOUN
biht-305	108	8	and	and	CCONJ
biht-305	108	9	digital	digital	ADJ
biht-305	108	10	health	health	NOUN
biht-305	108	11	technologies	technology	NOUN
biht-305	108	12	[	[	X
biht-305	108	13	internet	internet	NOUN
biht-305	108	14	]	]	PUNCT
biht-305	108	15	.	.	PUNCT
biht-305	109	1	fda	fda	PROPN
biht-305	109	2	;	;	PUNCT
biht-305	109	3	2023	2023	NUM
biht-305	109	4	[	[	PUNCT
biht-305	109	5	cited	cite	VERB
biht-305	109	6	2024	2024	NUM
biht-305	109	7	mar	mar	PROPN
biht-305	109	8	8	8	NUM
biht-305	109	9	]	]	PUNCT
biht-305	109	10	.	.	PUNCT
biht-305	110	1	available	available	ADJ
biht-305	110	2	from	from	ADP
biht-305	110	3	:	:	PUNCT
biht-305	110	4	https://www.fda	https://www.fda	PROPN
biht-305	110	5	.	.	PUNCT
biht-305	110	6	gov	gov	PROPN
biht-305	110	7	/	/	SYM
biht-305	110	8	drugs	drug	NOUN
biht-305	110	9	/	/	SYM
biht-305	110	10	news	news	NOUN
biht-305	110	11	-	-	PUNCT
biht-305	110	12	events	event	NOUN
biht-305	110	13	-	-	PUNCT
biht-305	110	14	human	human	NOUN
biht-305	110	15	-	-	PUNCT
biht-305	110	16	drugs	drug	NOUN
biht-305	110	17	/	/	SYM
biht-305	110	18	evolving	evolve	VERB
biht-305	110	19	-	-	PUNCT
biht-305	110	20	role	role	NOUN
biht-305	110	21	-	-	PUNCT
biht-305	110	22	decentralized	decentralize	VERB
biht-305	110	23	-	-	PUNCT
biht-305	110	24	clinical	clinical	ADJ
biht-305	110	25	-	-	PUNCT
biht-305	110	26	trials	trial	NOUN
biht-305	110	27	-	-	PUNCT
biht-305	110	28	and	and	CCONJ
biht-305	110	29	-	-	PUNCT
biht-305	110	30	digital	digital	ADJ
biht-305	110	31	-	-	PUNCT
biht-305	110	32	health	health	NOUN
biht-305	110	33	-	-	PUNCT
biht-305	110	34	technologies	technology	NOUN
biht-305	110	35	2	2	NUM
biht-305	110	36	.	.	PUNCT
biht-305	111	1	gaba	gaba	PROPN
biht-305	111	2	p	p	PROPN
biht-305	111	3	,	,	PUNCT
biht-305	111	4	bhatt	bhatt	PROPN
biht-305	111	5	dl	dl	PROPN
biht-305	111	6	.	.	PROPN
biht-305	112	1	the	the	DET
biht-305	112	2	covid-19	covid-19	PROPN
biht-305	112	3	pandemic	pandemic	NOUN
biht-305	112	4	:	:	PUNCT
biht-305	112	5	a	a	DET
biht-305	112	6	catalyst	catalyst	NOUN
biht-305	112	7	to	to	PART
biht-305	112	8	improve	improve	VERB
biht-305	112	9	clinical	clinical	ADJ
biht-305	112	10	trials	trial	NOUN
biht-305	112	11	.	.	PUNCT
biht-305	113	1	nat	nat	PROPN
biht-305	113	2	rev	rev	PROPN
biht-305	113	3	cardiol	cardiol	NOUN
biht-305	113	4	.	.	PUNCT
biht-305	114	1	2020;17(11):673–5	2020;17(11):673–5	X
biht-305	114	2	.	.	PUNCT
biht-305	115	1	https://doi.org/10.1038/s41569-020-00439-72	https://doi.org/10.1038/s41569-020-00439-72	ADP
biht-305	115	2	3	3	X
biht-305	115	3	.	.	X
biht-305	115	4	lamberti	lamberti	PROPN
biht-305	115	5	m	m	PROPN
biht-305	115	6	,	,	PUNCT
biht-305	115	7	smith	smith	PROPN
biht-305	115	8	z	z	PROPN
biht-305	115	9	,	,	PUNCT
biht-305	115	10	dirks	dirk	VERB
biht-305	115	11	a	a	PRON
biht-305	115	12	,	,	PUNCT
biht-305	115	13	caruana	caruana	PROPN
biht-305	115	14	t	t	PROPN
biht-305	115	15	,	,	PUNCT
biht-305	115	16	mitchell	mitchell	PROPN
biht-305	115	17	t	t	PROPN
biht-305	115	18	,	,	PUNCT
biht-305	115	19	getz	getz	PROPN
biht-305	115	20	k.	k.	PROPN
biht-305	115	21	the	the	DET
biht-305	115	22	impact	impact	NOUN
biht-305	115	23	of	of	ADP
biht-305	115	24	decentralized	decentralized	ADJ
biht-305	115	25	and	and	CCONJ
biht-305	115	26	hybrid	hybrid	ADJ
biht-305	115	27	trials	trial	NOUN
biht-305	115	28	on	on	ADP
biht-305	115	29	sponsor	sponsor	NOUN
biht-305	115	30	and	and	CCONJ
biht-305	115	31	cro	cro	NOUN
biht-305	115	32	collaborations	collaboration	NOUN
biht-305	116	1	[	[	X
biht-305	116	2	internet	internet	NOUN
biht-305	116	3	]	]	PUNCT
biht-305	116	4	.	.	PUNCT
biht-305	117	1	applied	apply	VERB
biht-305	117	2	clinical	clinical	ADJ
biht-305	117	3	trials	trial	NOUN
biht-305	117	4	online	online	ADV
biht-305	117	5	.	.	PUNCT
biht-305	118	1	[	[	X
biht-305	118	2	cited	cite	VERB
biht-305	118	3	2024	2024	NUM
biht-305	118	4	mar	mar	PROPN
biht-305	118	5	8	8	NUM
biht-305	118	6	]	]	PUNCT
biht-305	118	7	.	.	PUNCT
biht-305	119	1	available	available	ADJ
biht-305	119	2	from	from	ADP
biht-305	119	3	:	:	PUNCT
biht-305	119	4	https://www.appliedclinicaltrialsonline.com/view/the-impact-of-decentralized-and-hybrid-trials-on-sponsor-and-cro-collaborations	https://www.appliedclinicaltrialsonline.com/view/the-impact-of-decentralized-and-hybrid-trials-on-sponsor-and-cro-collaboration	NOUN
biht-305	119	5	4	4	NUM
biht-305	119	6	.	.	NOUN
biht-305	119	7	adesoye	adesoye	PROPN
biht-305	119	8	t	t	PROPN
biht-305	119	9	,	,	PUNCT
biht-305	119	10	katz	katz	PROPN
biht-305	119	11	mhg	mhg	PROPN
biht-305	119	12	,	,	PUNCT
biht-305	119	13	offodile	offodile	ADJ
biht-305	119	14	ac	ac	PROPN
biht-305	119	15	.	.	PUNCT
biht-305	120	1	meeting	meet	VERB
biht-305	120	2	trial	trial	NOUN
biht-305	120	3	participants	participant	NOUN
biht-305	120	4	where	where	SCONJ
biht-305	120	5	they	they	PRON
biht-305	120	6	are	be	AUX
biht-305	120	7	:	:	PUNCT
biht-305	120	8	decentralized	decentralize	VERB
biht-305	120	9	clinical	clinical	ADJ
biht-305	120	10	trials	trial	NOUN
biht-305	120	11	as	as	ADP
biht-305	120	12	a	a	DET
biht-305	120	13	patient	patient	NOUN
biht-305	120	14	-	-	PUNCT
biht-305	120	15	centered	center	VERB
biht-305	120	16	paradigm	paradigm	NOUN
biht-305	120	17	for	for	ADP
biht-305	120	18	enhancing	enhance	VERB
biht-305	120	19	accrual	accrual	ADJ
biht-305	120	20	and	and	CCONJ
biht-305	120	21	diversity	diversity	NOUN
biht-305	120	22	in	in	ADP
biht-305	120	23	surgical	surgical	ADJ
biht-305	120	24	and	and	CCONJ
biht-305	120	25	multidisciplinary	multidisciplinary	ADJ
biht-305	120	26	trials	trial	NOUN
biht-305	120	27	in	in	ADP
biht-305	120	28	oncology	oncology	NOUN
biht-305	120	29	.	.	PUNCT
biht-305	121	1	jco	jco	PROPN
biht-305	121	2	oncol	oncol	PROPN
biht-305	121	3	pract	pract	NOUN
biht-305	121	4	.	.	PUNCT
biht-305	122	1	2023;19(6):317–21	2023;19(6):317–21	X
biht-305	122	2	.	.	PUNCT
biht-305	123	1	https://doi.org/10.1200/op.22.00702	https://doi.org/10.1200/op.22.00702	NOUN
biht-305	123	2	5	5	NUM
biht-305	123	3	.	.	PUNCT
biht-305	124	1	rogers	rogers	PROPN
biht-305	124	2	em	em	PRON
biht-305	124	3	.	.	PUNCT
biht-305	125	1	diffusion	diffusion	NOUN
biht-305	125	2	of	of	ADP
biht-305	125	3	innovations	innovation	NOUN
biht-305	125	4	.	.	PUNCT
biht-305	126	1	5th	5th	ADJ
biht-305	126	2	ed	ed	NOUN
biht-305	126	3	.	.	PUNCT
biht-305	127	1	new	new	PROPN
biht-305	127	2	york	york	PROPN
biht-305	127	3	,	,	PUNCT
biht-305	127	4	ny	ny	PROPN
biht-305	127	5	:	:	PUNCT
biht-305	127	6	free	free	ADJ
biht-305	127	7	press	press	NOUN
biht-305	127	8	;	;	PUNCT
biht-305	127	9	2003	2003	NUM
biht-305	127	10	.	.	PUNCT
biht-305	128	1	6	6	NUM
biht-305	128	2	.	.	X
biht-305	128	3	emba	emba	PROPN
biht-305	128	4	iv	iv	PROPN
biht-305	128	5	-	-	PUNCT
biht-305	128	6	f	f	PROPN
biht-305	128	7	,	,	PUNCT
biht-305	128	8	mylrea	mylrea	PROPN
biht-305	128	9	m	m	PROPN
biht-305	128	10	,	,	PUNCT
biht-305	128	11	zhang	zhang	PROPN
biht-305	128	12	cy	cy	PROPN
biht-305	128	13	,	,	PUNCT
biht-305	128	14	wood	wood	NOUN
biht-305	128	15	tc	tc	NOUN
biht-305	128	16	,	,	PUNCT
biht-305	128	17	thornley	thornley	PROPN
biht-305	128	18	b.	b.	PROPN
biht-305	128	19	impact	impact	NOUN
biht-305	128	20	of	of	ADP
biht-305	128	21	blockchain	blockchain	PROPN
biht-305	128	22	-	-	ADJ
biht-305	128	23	digital	digital	ADJ
biht-305	128	24	twin	twin	ADJ
biht-305	128	25	technology	technology	NOUN
biht-305	128	26	on	on	ADP
biht-305	128	27	precision	precision	NOUN
biht-305	128	28	health	health	NOUN
biht-305	128	29	,	,	PUNCT
biht-305	128	30	pharmaceutical	pharmaceutical	NOUN
biht-305	128	31	industry	industry	NOUN
biht-305	128	32	,	,	PUNCT
biht-305	128	33	and	and	CCONJ
biht-305	128	34	life	life	NOUN
biht-305	128	35	sciences	science	NOUN
biht-305	128	36	conv2x	conv2x	VERB
biht-305	128	37	2023	2023	NUM
biht-305	128	38	report	report	NOUN
biht-305	128	39	[	[	X
biht-305	128	40	internet	internet	NOUN
biht-305	128	41	]	]	PUNCT
biht-305	128	42	.	.	PUNCT
biht-305	129	1	blockchain	blockchain	PROPN
biht-305	129	2	in	in	ADP
biht-305	129	3	healthcare	healthcare	PROPN
biht-305	129	4	today	today	NOUN
biht-305	129	5	.	.	PUNCT
biht-305	130	1	2023	2023	NUM
biht-305	130	2	nov	nov	NOUN
biht-305	130	3	8	8	NUM
biht-305	130	4	[	[	PUNCT
biht-305	130	5	cited	cite	VERB
biht-305	130	6	2024	2024	NUM
biht-305	130	7	mar	mar	PROPN
biht-305	130	8	8];6(2	8];6(2	NUM
biht-305	130	9	)	)	PUNCT
biht-305	130	10	.	.	PUNCT
biht-305	131	1	available	available	ADJ
biht-305	131	2	from	from	ADP
biht-305	131	3	:	:	PUNCT
biht-305	131	4	https://blockchainhealthcaretoday.com/index.php/journal/article/view/281	https://blockchainhealthcaretoday.com/index.php/journal/article/view/281	PROPN
biht-305	131	5	7	7	NUM
biht-305	131	6	.	.	PUNCT
biht-305	132	1	saeed	saeed	PROPN
biht-305	132	2	h	h	PROPN
biht-305	132	3	,	,	PUNCT
biht-305	132	4	malik	malik	PROPN
biht-305	132	5	h	h	PROPN
biht-305	132	6	,	,	PUNCT
biht-305	132	7	bashir	bashir	PROPN
biht-305	132	8	u	u	PROPN
biht-305	132	9	,	,	PUNCT
biht-305	132	10	ahmad	ahmad	PROPN
biht-305	132	11	a	a	PRON
biht-305	132	12	,	,	PUNCT
biht-305	132	13	riaz	riaz	PROPN
biht-305	132	14	s	s	PROPN
biht-305	132	15	,	,	PUNCT
biht-305	132	16	ilyas	ilyas	PROPN
biht-305	132	17	m	m	PROPN
biht-305	132	18	,	,	PUNCT
biht-305	132	19	et	et	PROPN
biht-305	132	20	al	al	PROPN
biht-305	132	21	.	.	PUNCT
biht-305	133	1	blockchain	blockchain	PROPN
biht-305	133	2	technology	technology	PROPN
biht-305	133	3	in	in	ADP
biht-305	133	4	healthcare	healthcare	PROPN
biht-305	133	5	:	:	PUNCT
biht-305	133	6	a	a	DET
biht-305	133	7	systematic	systematic	ADJ
biht-305	133	8	review	review	NOUN
biht-305	133	9	.	.	PUNCT
biht-305	134	1	plos	plos	PROPN
biht-305	134	2	one	one	NUM
biht-305	134	3	.	.	PUNCT
biht-305	135	1	2022	2022	NUM
biht-305	135	2	apr	apr	NOUN
biht-305	135	3	11;17(4):e0266462	11;17(4):e0266462	NUM
biht-305	135	4	.	.	PUNCT
biht-305	136	1	https://doi.org/10.1371/journal.pone.0266462	https://doi.org/10.1371/journal.pone.0266462	ADJ
biht-305	136	2	8	8	NUM
biht-305	136	3	.	.	PUNCT
biht-305	136	4	mcwhinney	mcwhinney	PROPN
biht-305	136	5	l.	l.	PROPN
biht-305	136	6	advancing	advance	VERB
biht-305	136	7	technology	technology	NOUN
biht-305	136	8	in	in	ADP
biht-305	136	9	decentralized	decentralize	VERB
biht-305	136	10	clinical	clinical	ADJ
biht-305	136	11	trials	trial	NOUN
biht-305	136	12	[	[	X
biht-305	136	13	internet	internet	NOUN
biht-305	136	14	]	]	PUNCT
biht-305	136	15	.	.	PUNCT
biht-305	137	1	[	[	X
biht-305	137	2	cited	cite	VERB
biht-305	137	3	2024	2024	NUM
biht-305	137	4	mar	mar	PROPN
biht-305	137	5	9	9	NUM
biht-305	137	6	]	]	PUNCT
biht-305	137	7	.	.	PUNCT
biht-305	138	1	available	available	ADJ
biht-305	138	2	from	from	ADP
biht-305	138	3	:	:	PUNCT
biht-305	138	4	https://isrreports	https://isrreport	NOUN
biht-305	138	5	.	.	NOUN
biht-305	138	6	com	com	NOUN
biht-305	138	7	/	/	SYM
biht-305	138	8	advancing	advance	VERB
biht-305	138	9	-	-	PUNCT
biht-305	138	10	clinical	clinical	ADJ
biht-305	138	11	-	-	PUNCT
biht-305	138	12	research	research	NOUN
biht-305	138	13	-	-	PUNCT
biht-305	138	14	with	with	ADP
biht-305	138	15	-	-	PUNCT
biht-305	138	16	advanced	advance	VERB
biht-305	138	17	-	-	PUNCT
biht-305	138	18	technology/	technology/	NUM
biht-305	138	19	9	9	NUM
biht-305	138	20	.	.	PUNCT
biht-305	139	1	speed	speed	NOUN
biht-305	139	2	up	up	ADP
biht-305	139	3	biopharma	biopharma	NOUN
biht-305	139	4	clinical	clinical	ADJ
biht-305	139	5	trials	trial	NOUN
biht-305	139	6	to	to	PART
biht-305	139	7	boost	boost	VERB
biht-305	139	8	r&d	r&d	NOUN
biht-305	139	9	output	output	NOUN
biht-305	139	10	|	|	ADV
biht-305	139	11	mckinsey	mckinsey	NOUN
biht-305	140	1	[	[	X
biht-305	140	2	internet	internet	NOUN
biht-305	140	3	]	]	PUNCT
biht-305	140	4	.	.	PUNCT
biht-305	141	1	www.mckinsey.com	www.mckinsey.com	X
biht-305	141	2	.	.	PUNCT
biht-305	142	1	[	[	X
biht-305	142	2	cited	cite	VERB
biht-305	142	3	2024	2024	NUM
biht-305	142	4	mar	mar	PROPN
biht-305	142	5	8	8	NUM
biht-305	142	6	]	]	PUNCT
biht-305	142	7	.	.	PUNCT
biht-305	143	1	available	available	ADJ
biht-305	143	2	from	from	ADP
biht-305	143	3	:	:	PUNCT
biht-305	143	4	https://www.mckinsey.com/industries/life-sciences/	https://www.mckinsey.com/industries/life-sciences/	PUNCT
biht-305	143	5	our	our	PRON
biht-305	143	6	-	-	PUNCT
biht-305	143	7	insights	insight	NOUN
biht-305	143	8	/	/	SYM
biht-305	143	9	accelerating	accelerate	VERB
biht-305	143	10	-	-	PUNCT
biht-305	143	11	clinical	clinical	ADJ
biht-305	143	12	-	-	PUNCT
biht-305	143	13	trials	trial	NOUN
biht-305	143	14	-	-	PUNCT
biht-305	143	15	to	to	ADP
biht-305	143	16	-	-	PUNCT
biht-305	143	17	improve	improve	VERB
biht-305	143	18	-	-	PUNCT
biht-305	143	19	biopharma	biopharma	NOUN
biht-305	143	20	-	-	PUNCT
biht-305	143	21	r	r	NOUN
biht-305	143	22	-	-	PUNCT
biht-305	143	23	and	and	CCONJ
biht-305	143	24	-	-	PUNCT
biht-305	143	25	d	d	NOUN
biht-305	143	26	-	-	NOUN
biht-305	143	27	productivity	productivity	NOUN
biht-305	143	28	10	10	NUM
biht-305	143	29	.	.	PUNCT
biht-305	144	1	mak	mak	PROPN
biht-305	144	2	bc	bc	PROPN
biht-305	144	3	,	,	PUNCT
biht-305	144	4	addeman	addeman	PROPN
biht-305	144	5	bt	bt	PROPN
biht-305	144	6	,	,	PUNCT
biht-305	144	7	chen	chen	PROPN
biht-305	144	8	j	j	PROPN
biht-305	144	9	,	,	PUNCT
biht-305	144	10	papp	papp	PROPN
biht-305	144	11	ka	ka	PROPN
biht-305	144	12	,	,	PUNCT
biht-305	144	13	gooderham	gooderham	PROPN
biht-305	144	14	mj	mj	PROPN
biht-305	144	15	,	,	PUNCT
biht-305	144	16	guenther	guenther	PROPN
biht-305	144	17	lc	lc	PROPN
biht-305	144	18	,	,	PUNCT
biht-305	144	19	et	et	PROPN
biht-305	144	20	al	al	PROPN
biht-305	144	21	.	.	PUNCT
biht-305	144	22	leveraging	leverage	VERB
biht-305	144	23	blockchain	blockchain	PROPN
biht-305	144	24	technology	technology	NOUN
biht-305	144	25	for	for	ADP
biht-305	144	26	informed	informed	ADJ
biht-305	144	27	consent	consent	NOUN
biht-305	144	28	process	process	NOUN
biht-305	144	29	and	and	CCONJ
biht-305	144	30	patient	patient	ADJ
biht-305	144	31	engagement	engagement	NOUN
biht-305	144	32	in	in	ADP
biht-305	144	33	a	a	DET
biht-305	144	34	clinical	clinical	ADJ
biht-305	144	35	trial	trial	NOUN
biht-305	144	36	pilot	pilot	NOUN
biht-305	144	37	.	.	PUNCT
biht-305	145	1	blockchain	blockchain	PROPN
biht-305	145	2	healthc	healthc	PROPN
biht-305	145	3	today	today	NOUN
biht-305	145	4	.	.	PUNCT
biht-305	146	1	2021;4	2021;4	NOUN
biht-305	146	2	.	.	PUNCT
biht-305	147	1	https://doi	https://doi	PROPN
biht-305	147	2	.	.	PUNCT
biht-305	148	1	org/10.30953	org/10.30953	PROPN
biht-305	148	2	/	/	SYM
biht-305	148	3	bhty.v4.182	bhty.v4.182	NOUN
biht-305	148	4	11	11	NUM
biht-305	148	5	.	.	PUNCT
biht-305	148	6	decentralized	decentralize	VERB
biht-305	148	7	trials	trial	NOUN
biht-305	148	8	&	&	CCONJ
biht-305	148	9	research	research	PROPN
biht-305	148	10	alliance	alliance	NOUN
biht-305	148	11	release	release	NOUN
biht-305	148	12	best	good	ADJ
biht-305	148	13	practices	practice	NOUN
biht-305	148	14	rubric	rubric	ADJ
biht-305	148	15	to	to	PART
biht-305	148	16	provide	provide	VERB
biht-305	148	17	framework	framework	NOUN
biht-305	148	18	to	to	PART
biht-305	148	19	evaluate	evaluate	VERB
biht-305	148	20	dct	dct	NOUN
biht-305	148	21	processes	process	NOUN
biht-305	148	22	[	[	X
biht-305	148	23	internet	internet	NOUN
biht-305	148	24	]	]	PUNCT
biht-305	148	25	.	.	PUNCT
biht-305	149	1	www.dtra.org	www.dtra.org	X
biht-305	149	2	.	.	PUNCT
biht-305	150	1	[	[	X
biht-305	150	2	cited	cite	VERB
biht-305	150	3	2024	2024	NUM
biht-305	150	4	mar	mar	PROPN
biht-305	150	5	8	8	NUM
biht-305	150	6	]	]	PUNCT
biht-305	150	7	.	.	PUNCT
biht-305	151	1	available	available	ADJ
biht-305	151	2	from	from	ADP
biht-305	151	3	:	:	PUNCT
biht-305	151	4	https://www.dtra.org/dtra-press-releases/decentralized-trials-research-alliance-release-best-practices-rubric-to-provide-framework-to-evaluate-dct-processes	https://www.dtra.org/dtra-press-releases/decentralized-trials-research-alliance-release-best-practices-rubric-to-provide-framework-to-evaluate-dct-processe	NOUN
biht-305	151	5	12	12	NUM
biht-305	151	6	.	.	PUNCT
biht-305	152	1	decentralized	decentralize	VERB
biht-305	152	2	clinical	clinical	ADJ
biht-305	152	3	trials	trial	NOUN
biht-305	152	4	for	for	ADP
biht-305	152	5	drugs	drug	NOUN
biht-305	152	6	,	,	PUNCT
biht-305	152	7	biological	biological	ADJ
biht-305	152	8	products	product	NOUN
biht-305	152	9	,	,	PUNCT
biht-305	152	10	and	and	CCONJ
biht-305	152	11	devices	device	NOUN
biht-305	152	12	guidance	guidance	NOUN
biht-305	152	13	for	for	ADP
biht-305	152	14	industry	industry	NOUN
biht-305	152	15	,	,	PUNCT
biht-305	152	16	investigators	investigator	NOUN
biht-305	152	17	,	,	PUNCT
biht-305	152	18	and	and	CCONJ
biht-305	152	19	other	other	ADJ
biht-305	152	20	stakeholders	stakeholder	NOUN
biht-305	152	21	draft	draft	VERB
biht-305	152	22	guidance	guidance	NOUN
biht-305	152	23	[	[	X
biht-305	152	24	internet	internet	NOUN
biht-305	152	25	]	]	X
biht-305	152	26	.	.	PUNCT
biht-305	153	1	2023	2023	NUM
biht-305	154	1	[	[	X
biht-305	154	2	cited	cite	VERB
biht-305	154	3	2024	2024	NUM
biht-305	154	4	mar	mar	PROPN
biht-305	154	5	8	8	NUM
biht-305	154	6	]	]	PUNCT
biht-305	154	7	.	.	PUNCT
biht-305	155	1	available	available	ADJ
biht-305	155	2	from	from	ADP
biht-305	155	3	:	:	PUNCT
biht-305	155	4	https://www.fda.gov/media/167696/download	https://www.fda.gov/media/167696/download	PROPN
biht-305	155	5	13	13	NUM
biht-305	155	6	.	.	PUNCT
biht-305	156	1	galis	galis	PROPN
biht-305	156	2	m.	m.	PROPN
biht-305	156	3	council	council	PROPN
biht-305	156	4	post	post	PROPN
biht-305	156	5	:	:	PUNCT
biht-305	156	6	blockchain	blockchain	PROPN
biht-305	156	7	and	and	CCONJ
biht-305	156	8	data	datum	NOUN
biht-305	156	9	privacy	privacy	NOUN
biht-305	156	10	:	:	PUNCT
biht-305	156	11	the	the	DET
biht-305	156	12	future	future	NOUN
biht-305	156	13	of	of	ADP
biht-305	156	14	technology	technology	NOUN
biht-305	156	15	compliance	compliance	NOUN
biht-305	157	1	[	[	X
biht-305	157	2	internet	internet	NOUN
biht-305	157	3	]	]	PUNCT
biht-305	157	4	.	.	PUNCT
biht-305	158	1	forbes	forbes	PROPN
biht-305	158	2	.	.	PUNCT
biht-305	159	1	[	[	X
biht-305	159	2	cited	cite	VERB
biht-305	159	3	2024	2024	NUM
biht-305	159	4	apr	apr	NOUN
biht-305	159	5	13	13	NUM
biht-305	159	6	]	]	PUNCT
biht-305	159	7	.	.	PUNCT
biht-305	160	1	available	available	ADJ
biht-305	160	2	from	from	ADP
biht-305	160	3	:	:	PUNCT
biht-305	160	4	https://www.forbes.com/sites/forbestechcouncil/2024/02/15/blockchain-and-data-privacy-the-future-of-technology-compliance/?sh=40b4c31a74f8	https://www.forbes.com/sites/forbestechcouncil/2024/02/15/blockchain-and-data-privacy-the-future-of-technology-compliance/?sh=40b4c31a74f8	NOUN
biht-305	160	5	copyright	copyright	NOUN
biht-305	160	6	ownership	ownership	NOUN
biht-305	160	7	:	:	PUNCT
biht-305	160	8	this	this	PRON
biht-305	160	9	is	be	AUX
biht-305	160	10	an	an	DET
biht-305	160	11	open	open	ADJ
biht-305	160	12	-	-	PUNCT
biht-305	160	13	access	access	NOUN
biht-305	160	14	article	article	NOUN
biht-305	160	15	distributed	distribute	VERB
biht-305	160	16	in	in	ADP
biht-305	160	17	accordance	accordance	NOUN
biht-305	160	18	with	with	ADP
biht-305	160	19	the	the	DET
biht-305	160	20	creative	creative	ADJ
biht-305	160	21	commons	common	NOUN
biht-305	160	22	attribution	attribution	NOUN
biht-305	160	23	non	non	ADJ
biht-305	160	24	-	-	ADJ
biht-305	160	25	commercial	commercial	ADJ
biht-305	160	26	(	(	PUNCT
biht-305	160	27	cc	cc	NOUN
biht-305	160	28	by	by	ADP
biht-305	160	29	-	-	PUNCT
biht-305	160	30	nc	nc	PROPN
biht-305	160	31	4.0	4.0	NUM
biht-305	160	32	)	)	PUNCT
biht-305	160	33	license	license	NOUN
biht-305	160	34	,	,	PUNCT
biht-305	160	35	which	which	PRON
biht-305	160	36	permits	permit	VERB
biht-305	160	37	others	other	NOUN
biht-305	160	38	to	to	PART
biht-305	160	39	distribute	distribute	VERB
biht-305	160	40	,	,	PUNCT
biht-305	160	41	adapt	adapt	VERB
biht-305	160	42	,	,	PUNCT
biht-305	160	43	enhance	enhance	VERB
biht-305	160	44	this	this	DET
biht-305	160	45	work	work	NOUN
biht-305	160	46	non	non	ADJ
biht-305	160	47	-	-	ADJ
biht-305	160	48	commercially	commercially	ADV
biht-305	160	49	,	,	PUNCT
biht-305	160	50	and	and	CCONJ
biht-305	160	51	license	license	VERB
biht-305	160	52	their	their	PRON
biht-305	160	53	derivative	derivative	ADJ
biht-305	160	54	works	work	NOUN
biht-305	160	55	on	on	ADP
biht-305	160	56	different	different	ADJ
biht-305	160	57	terms	term	NOUN
biht-305	160	58	,	,	PUNCT
biht-305	160	59	provided	provide	VERB
biht-305	160	60	the	the	DET
biht-305	160	61	original	original	ADJ
biht-305	160	62	work	work	NOUN
biht-305	160	63	is	be	AUX
biht-305	160	64	properly	properly	ADV
biht-305	160	65	cited	cite	VERB
biht-305	160	66	,	,	PUNCT
biht-305	160	67	and	and	CCONJ
biht-305	160	68	the	the	DET
biht-305	160	69	use	use	NOUN
biht-305	160	70	is	be	AUX
biht-305	160	71	non	non	ADJ
biht-305	160	72	-	-	ADJ
biht-305	160	73	commercial	commercial	ADJ
biht-305	160	74	.	.	PUNCT
biht-305	161	1	see	see	VERB
biht-305	161	2	http://creativecommons	http://creativecommon	NOUN
biht-305	161	3	.	.	PUNCT
biht-305	161	4	org	org	ADJ
biht-305	161	5	/	/	SYM
biht-305	161	6	licenses	license	NOUN
biht-305	161	7	/	/	SYM
biht-305	161	8	by	by	ADP
biht-305	161	9	-	-	PUNCT
biht-305	161	10	nc/4.0	nc/4.0	NOUN
biht-305	161	11	https://doi.org/10.30953/bhty.v7.305	https://doi.org/10.30953/bhty.v7.305	NOUN
biht-305	161	12	https://www.fda.gov/drugs/news-events-human-drugs/evolving-role-decentralized-clinical-trials-and-digital-health-technologies	https://www.fda.gov/drugs/news-events-human-drugs/evolving-role-decentralized-clinical-trials-and-digital-health-technologie	NOUN
biht-305	161	13	https://www.fda.gov/drugs/news-events-human-drugs/evolving-role-decentralized-clinical-trials-and-digital-health-technologies	https://www.fda.gov/drugs/news-events-human-drugs/evolving-role-decentralized-clinical-trials-and-digital-health-technologie	NOUN
biht-305	161	14	https://www.fda.gov/drugs/news-events-human-drugs/evolving-role-decentralized-clinical-trials-and-digital-health-technologies	https://www.fda.gov/drugs/news-events-human-drugs/evolving-role-decentralized-clinical-trials-and-digital-health-technologie	NOUN
biht-305	161	15	https://doi.org/10.1038/s41569-020-00439-72	https://doi.org/10.1038/s41569-020-00439-72	NOUN
biht-305	161	16	https://www.appliedclinicaltrialsonline.com/view/the-impact-of-decentralized-and-hybrid-trials-on-sponsor-and-cro-collaborations	https://www.appliedclinicaltrialsonline.com/view/the-impact-of-decentralized-and-hybrid-trials-on-sponsor-and-cro-collaboration	NOUN
biht-305	161	17	https://www.appliedclinicaltrialsonline.com/view/the-impact-of-decentralized-and-hybrid-trials-on-sponsor-and-cro-collaborations	https://www.appliedclinicaltrialsonline.com/view/the-impact-of-decentralized-and-hybrid-trials-on-sponsor-and-cro-collaboration	NOUN
biht-305	161	18	https://www.appliedclinicaltrialsonline.com/view/the-impact-of-decentralized-and-hybrid-trials-on-sponsor-and-cro-collaborations	https://www.appliedclinicaltrialsonline.com/view/the-impact-of-decentralized-and-hybrid-trials-on-sponsor-and-cro-collaboration	NOUN
biht-305	161	19	https://doi.org/10.1200/op.22.00702	https://doi.org/10.1200/op.22.00702	PUNCT
biht-305	162	1	https://blockchainhealthcaretoday.com/index.php/journal/article/view/281	https://blockchainhealthcaretoday.com/index.php/journal/article/view/281	INTJ
biht-305	162	2	https://blockchainhealthcaretoday.com/index.php/journal/article/view/281	https://blockchainhealthcaretoday.com/index.php/journal/article/view/281	PROPN
biht-305	162	3	https://doi.org/10.1371/journal.pone.0266462	https://doi.org/10.1371/journal.pone.0266462	PROPN
biht-305	162	4	https://doi.org/10.1371/journal.pone.0266462	https://doi.org/10.1371/journal.pone.0266462	PROPN
biht-305	162	5	https://isrreports.com/advancing-clinical-research-with-advanced-technology/	https://isrreports.com/advancing-clinical-research-with-advanced-technology/	PROPN
biht-305	162	6	https://isrreports.com/advancing-clinical-research-with-advanced-technology/	https://isrreports.com/advancing-clinical-research-with-advanced-technology/	PROPN
biht-305	162	7	http://www.mckinsey.com	http://www.mckinsey.com	PUNCT
biht-305	162	8	https://www.mckinsey.com/industries/life-sciences/our-insights/accelerating-clinical-trials-to-improve-biopharma-r-and-d-productivity	https://www.mckinsey.com/industries/life-sciences/our-insights/accelerating-clinical-trials-to-improve-biopharma-r-and-d-productivity	NOUN
biht-305	162	9	https://www.mckinsey.com/industries/life-sciences/our-insights/accelerating-clinical-trials-to-improve-biopharma-r-and-d-productivity	https://www.mckinsey.com/industries/life-sciences/our-insights/accelerating-clinical-trials-to-improve-biopharma-r-and-d-productivity	NOUN
biht-305	162	10	https://www.mckinsey.com/industries/life-sciences/our-insights/accelerating-clinical-trials-to-improve-biopharma-r-and-d-productivity	https://www.mckinsey.com/industries/life-sciences/our-insights/accelerating-clinical-trials-to-improve-biopharma-r-and-d-productivity	NOUN
biht-305	162	11	https://doi.org/10.30953/bhty.v4.182	https://doi.org/10.30953/bhty.v4.182	NOUN
biht-305	162	12	https://doi.org/10.30953/bhty.v4.182	https://doi.org/10.30953/bhty.v4.182	PROPN
biht-305	162	13	http://www.dtra.org	http://www.dtra.org	PROPN
biht-305	162	14	https://www.dtra.org/dtra-press-releases/decentralized-trials-research-alliance-release-best-practices-rubric-to-provide-framework-to-evaluate-dct-processes	https://www.dtra.org/dtra-press-releases/decentralized-trials-research-alliance-release-best-practices-rubric-to-provide-framework-to-evaluate-dct-processe	VERB
biht-305	162	15	https://www.dtra.org/dtra-press-releases/decentralized-trials-research-alliance-release-best-practices-rubric-to-provide-framework-to-evaluate-dct-processes	https://www.dtra.org/dtra-press-releases/decentralized-trials-research-alliance-release-best-practices-rubric-to-provide-framework-to-evaluate-dct-processe	NOUN
biht-305	162	16	https://www.dtra.org/dtra-press-releases/decentralized-trials-research-alliance-release-best-practices-rubric-to-provide-framework-to-evaluate-dct-processes	https://www.dtra.org/dtra-press-releases/decentralized-trials-research-alliance-release-best-practices-rubric-to-provide-framework-to-evaluate-dct-processe	NOUN
biht-305	162	17	https://www.fda.gov/media/167696/download	https://www.fda.gov/media/167696/download	X
biht-305	162	18	https://www.forbes.com/sites/forbestechcouncil/2024/02/15/blockchain-and-data-privacy-the-future-of-technology-compliance/?sh=40b4c31a74f8	https://www.forbes.com/sites/forbestechcouncil/2024/02/15/blockchain-and-data-privacy-the-future-of-technology-compliance/?sh=40b4c31a74f8	PROPN
biht-305	162	19	https://www.forbes.com/sites/forbestechcouncil/2024/02/15/blockchain-and-data-privacy-the-future-of-technology-compliance/?sh=40b4c31a74f8	https://www.forbes.com/sites/forbestechcouncil/2024/02/15/blockchain-and-data-privacy-the-future-of-technology-compliance/?sh=40b4c31a74f8	PROPN
biht-305	162	20	https://www.forbes.com/sites/forbestechcouncil/2024/02/15/blockchain-and-data-privacy-the-future-of-technology-compliance/?sh=40b4c31a74f8	https://www.forbes.com/sites/forbestechcouncil/2024/02/15/blockchain-and-data-privacy-the-future-of-technology-compliance/?sh=40b4c31a74f8	NOUN